San Jose State University

SJSU ScholarWorks
Master's Theses

Master's Theses and Graduate Research

2008

Characterization of human copper/zinc superoxide dismutase
Nada Khouderchah
San Jose State University

Follow this and additional works at: https://scholarworks.sjsu.edu/etd_theses

Recommended Citation
Khouderchah, Nada, "Characterization of human copper/zinc superoxide dismutase" (2008). Master's
Theses. 3631.
DOI: https://doi.org/10.31979/etd.r7ms-5pe6
https://scholarworks.sjsu.edu/etd_theses/3631

This Thesis is brought to you for free and open access by the Master's Theses and Graduate Research at SJSU
ScholarWorks. It has been accepted for inclusion in Master's Theses by an authorized administrator of SJSU
ScholarWorks. For more information, please contact scholarworks@sjsu.edu.

Yamazaki, K.; Iwura, T.; Ishikawa, R.; Ozaki, Y. Methanol-induced tertiary and
secondary structure changes of granulocyte-colony stimulating factor. J. Biochem.
(Tokyo) 2006, 140, 49-56.
Zhang, F.; Zhu, H. Intracellular conformational alterations of mutant SOD1 and the
implications for ALS-associated SOD1 mutant induced motor neuron cell death.
Biochim. Biophys. Acta, 2006, 1760, 404-414.
Zhou, H. X.; Dill, K. A. Stabilization of proteins in confined spaces. Biochemistry 2001,
40,11289-11293.
Zimmerman, S. B.; Minton, A. P. Macromolecular crowding: biochemical, biophysical
and physiological consequences. Annu. Rev. Biophys. Biomol. Struct. 1993, 22,
27-65.

122

CHARACTERIZATION OF HUMAN COPPER/ZINC SUPEROXIDE DISMUTASE

A Thesis
Presented to
The Faculty of the Department of Chemistry
San Jose State University

In Partial Fulfillment
of the Requirements for the Degree
Masters of Science

by
Nada Khouderchah
December 2008

UMI Number: 1463390

INFORMATION TO USERS

The quality of this reproduction is dependent upon the quality of the copy
submitted. Broken or indistinct print, colored or poor quality illustrations and
photographs, print bleed-through, substandard margins, and improper
alignment can adversely affect reproduction.
In the unlikely event that the author did not send a complete manuscript
and there are missing pages, these will be noted. Also, if unauthorized
copyright material had to be removed, a note will indicate the deletion.

®

UMI
UMI Microform 1463390
Copyright 2009 by ProQuest LLC.
All rights reserved. This microform edition is protected against
unauthorized copying under Title 17, United States Code.
ProQuest LLC
789 E. Eisenhower Parkway
PO Box 1346
Ann Arbor, Ml 48106-1346

©2008
Nada Khouderchah
ALL RIGHTS RESERVED

SAN JOSE STATE UNIVERSITY
The Undersigned Thesis Committee Approves the Thesis Titled
CHARACTERIZATION OF HUMAN COPPER/ZINC SUPEROXIDE DISMUTASE
by
Nada Khouderchah

APPROVED FOR THE DEPARTMENT OF CHEMISTRY

itW

f-£jdr^2sr

Dr. Daryl Egg^s,

Dr. Brooke Lustig,

Date

Department of Chemistry

Date

*^t% 5 a s ^^
Dr. Gilles MuIIer,

//-P-ofc

\ ^fepartment of Chemistry

\\lot>)o%
Department of Chemistry

Date

APPROVED FOR THE UNIVERSITY

Associate Dean

Date

ABSTRACT
CHARACTERIZATION OF HUMAN COPPER/ZINC SUPEROXIDE DISMUTASE
by Nada Khouderchah
In this research, both human wild type (WT) and mutant A4V SOD1 were
encapsulated in wet-aged sol-gel glasses in an attempt to identify intermediates leading to
aggregation. The encapsulated proteins were subjected to various conditions known to
cause aggregation in solution such as heat, low pH ~ 4.0, EDTA, TCEP or DTT, and
TFE. Changes in the secondary structure of the entrapped SOD1 were monitored by
using circular dichroism (CD) in the far-UV region.
Results showed major differences between the WT and A4V SOD1 secondary
structures under most conditions. The encapsulation method is shown to enable longterm monitoring of the secondary structural changes over several months, and the optimal
encapsulation method for the SOD1 is identified in order to minimize leaching. Finally, a
possible common intermediate for both A4V and WT SOD1 was identified under
different conditions.
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CHAPTER 1
1.0 Introduction
1.1

Overview
Amyotrophic lateral sclerosis (ALS), also called Lou Gehrig's disease, is a

progressive neurodegenerative disease that targets, and eventually destroys, the motor
neurons in the spinal cord and brainstem (Bruijn et al., 2004). People of all races and
ethnic backgrounds are affected. ALS cases are generally classified into two different
groups: familial ALS (FALS), where a family history of the disease can be traced to a
genetic defect, and sporadic ALS (SALS) (Rosen et al., 1993). FALS represents about
5%-10% of the total number of ALS cases. In 20%-25% of FALS cases, the cause of the
disease has been found to be associated with a genetic defect on chromosome 21 that
codes for an important antioxidant enzyme called copper-zinc superoxide dismutase
(CuZnSOD) (Bruijin et al., 2004; Valentine et al., 2005; Andersen et al, 2006). Even
though this percentage is very small (l%-2.5% of the total number of ALS cases),
understanding the mechanism by which the mutant SOD1 causes the disease may be a
crucial step to unlocking the mystery of ALS in general. In fact, the common clinical
symptoms of FALS and SALS suggest that the disease mechanism could also be common
(Li et al., 1988). Thus, the effects of SOD1 mutations at the cellular and biological level
may be relevant not only in FALS cases but in other ALS cases as well.
The discovery of mutations in SOD1 that provided the first insight into the
molecular basis of ALS was reported in 1993 (Rosen et al., 1993). To date, over 100
different mutations have been identified and linked to ALS (http://www.alsod.org).
Unfortunately, these mutations are widely scattered throughout the SOD1 structure,
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which does not help in isolating a common denominator of the disease mechanism.
Nevertheless, most of the evidence suggests that these mutations cause the
neurodegenerative disease by adding a toxic function to the protein (Valentine et al.,
2005). This toxic property leads to an increased propensity for the pathogenic SOD1 to
aggregate relative to the wild type (WT) protein (Ray et al., 2004; Meiering 2008) and to
form amyloid-like fibrils (Bruijn et al., 2004). Aggregation usually occurs when a
protein misfolds to a non-native conformation and fails to be degraded or to refold back
to the native conformation. Consequently, the protein aggregate becomes the direct or
indirect cause of the pathological conditions related to the disease (Dobson, 1999; Wang
et al., 2008). Indeed, it was reported that the SOD1 mutants adopted different
conformations than WT in vivo. These altered conformations of SOD1 mutants were
observed prior to the formation of protein aggregates (Zhang and Zhu, 2006). Also, the
crystal structures of two different mutants, A4V and II13T, showed large conformational
changes as compared with the WT SOD1 in solutions (Hough et al., 2004). These results
suggest that the conformational changes and the aggregate formation play an important
role in the origin of the disease. Therefore, the detection and isolation of intermediates
that could lead to aggregation are the obvious next steps. Our current knowledge of the
pathogenic mechanisms of ALS is based mostly on studies with various mutant SOD Is in
solution where the protein tends to aggregate with itself rather quickly (Valentine et al.,
2005; Banci et al., 2007; Cao et al., 2008). Thus, an alternate approach is needed to
facilitate the detection of the intermediates leading to aggregation.
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A summary of the latest literature related to this thesis is provided in this chapter,
including the functions, structures, and findings of the protein SOD1 (WT and A4V
mutant), as well as the sol-gel method of protein encapsulation.

1.2

Overview of Experimental Goals
The objective of this research is to detect possible intermediate(s) that could lead

to protein aggregation by using the sol-gel encapsulation method. In this study, we
encapsulate human SOD1 WT and mutant A4V proteins in silica glasses where every
protein molecule is isolated in an attempt to prevent protein aggregation while applying
various conditions that normally lead to aggregation in solution. The conditions used
were: lowering the pH to 3.5, using the metal chelator ethylenediaminetetraacetic acid
(EDTA) (DiDonato et al., 2003), adding mild denaturants such as 2, 2, 2-trifiuoroethanol
(TFE), using heat treatment (Stathopulos et al, 2003), or reducing the disulfide bond with
either dithiothreitol (DTT) or Tris (2-carboxyethyl) phosphine hydrochloride (TCEP)
(Tiwari and Hayward 2003; Arnesano et al., 2004). Also, the effect of the salt
tetramethylammonium chloride N(CH3)4C1 on SOD1 was investigated. Circular
dichroism (CD) was used to observe conformational changes in the secondary structure
of the encapsulated proteins.

1.3

Structure of the Protein
The human enzyme CuZnSOD is a 32-kDa homodimer with ellipsoidal

dimensions of about 30x40x70 A in size. SOD1 is a stable enzyme. It is resistant to
proteolysis and to inactivation by chemical denaturants such as 4% sodium dodecyl
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sulfate (SDS) and 10 M urea (Forman and Fridovich, 1973; Marklund et al, 1997). In
addition, fully metallated SOD1 unfolds at a temperature above 80°C (Rodriguez et al.,
2002). The unusual stability of SOD1 is due to its structural properties, which consist of
an eight-stranded P-barrel motif, binding sites for copper and zinc ions, an intrasubunit
disulfide bond, hydrophobic interactions, and a network of hydrogen bonds (Valentine et
al., 2005; Shaw and Valentine 2006).
SOD1 is a dimeric protein. Each subunit contains 153 amino acid residues, an
internal disulfide bond, one copper and one zinc ion (Parge et al., 1992) (see Figure 1).

Figure 1. Crystal structure of metal bound human SOD1 (figure from PDB, ID 2C9V).
Copper ions are shown as orange spheres, and zinc ions as blue spheres.
The two subunits are held together by hydrophobic interactions (Lynch et al.,
2004). Each subunit is arranged in a Greek key P-barrel structure composed of eight

4

antiparallel P-strands joined by seven external loops. Loops I, II and V form connections
between adjacent strands. Loop IV (residues 49-84) is involved in interactions between
the two subunits and contains Cys57, the zinc binding domain and part of the active site
cavity. Cys57 forms an internal disulfide bond with Cys146. Loop VII (residues 121-144)
is the electrostatic loop that plays a role in substrate attraction. Loop VI (residues 102114) contributes to the stability of the enzyme. Specifically, Leu106 and Leu38 act to
stabilize the opposite ends of the P-barrel fold and the dimer interface. Each amino acid
points its side-chain into the core of the P-barrel and stabilizes the structure through
hydrophobic interactions (DiDonato et al., 2003; Fujiwara et al., 2005). Loop VI together
with loop III (residues 37-40) forms the Greek- key connection across the P-barrel (Parge
et al., 1992) (see Figure 2).

Figure 2. Schematic drawing of the SOD1 structure, as adapted from Parge et al., 1992.
P-sheets are shown as open arrows and enumerated in chronological order using Arabic
numbers. Loops are drawn as lines and numbered using Roman numerals.
The H-bond network contributes to the protein stability. For instance, a network
of hydrogen bonds stabilizes the P-barrel structure and forms bridges between the loops,
metal binding sites and structural elements of the subunit. Asp124 in the electrostatic loop
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is hydrogen bonded to the non-ligating nitrogens of the copper ligand His and the zinc
ligand His71. Also, the carbonyl oxygen on Gly141 in the electrostatic loop is hydrogen
bonded to the non-ligating nitrogen of copper ligand His120. Furthermore, the copper
binding site is connected to both the electrostatic and the disulfide loops through
hydrogen bonds between the non-ligating nitrogen of His , a copper ligand, and the
carbonyl oxygen of Gly61, which is hydrogen bonded with the catalytically important
Arg143. In turn, Arg143 is hydrogen bonded to the carbonyl oxygen of Cys57 positioned in
the disulfide loop and compromises part of the dimer interface. Also, Cys57 is involved
in the intrasubunit disulfide bond with Cys146 located in P-sheet 8. Moreover, part of Psheet 8 is hydrogen bonded to Gly114 and Arg115 in the Greek key loop VI (Parge et al.,
1992; Valentine et al., 2005). So as observed, the hydrogen bond network connects and
stabilizes the monomer subunit of hSODl. Furthermore, the binding of metals as well as
the formation of intrasubunit disulfide bond between Cys57 and Cys146 stabilize the dimer
structure and shift the equilibrium from monomer to dimer species.

1.3.1

Role of Metals
Each subunit contains one copper and one zinc ion. While the copper is

coordinated by four histidine ligands (His46, His48, His63 and His120) and one water
f\(\

71

&ft

molecule, the zinc ion is coordinated by three histidine ligands (His , His and His )
and one Asp . The copper and zinc ions share an imidazolate ligand, His (Parge et al.,
1992) (see Figure 3).
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The copper ion is solvent exposed, whereas the zinc ion is buried inside the (3barrel (Fridovich, 1975). The copper ion is responsible for the catalytic activity of the
hSODl protein. The Zn2+ ion plays a role in stabilizing the structure, adding a positive
charge (Band et al, 2003) and providing, in yeast and human, the correct structure for
productive interaction with its copper chaperone (CCS) (Furukawa et al., 2004). This
suggests that the zinc ion is inserted before the copper ion. At this time, the process of
zinc binding and the source of zinc ion in vivo are still unknown (Banci et al., 2003).
Once the copper ion is added, the disulfide bond formation between Cys57 and Cys 4
follows, and dimerization occurs in the holo-SODl protein (holo refers to fullymetallated SOD1 protein).

Figure 3. Schematic drawing of the metal binding of hSODl in the oxidized form. The
Cu2+ is coordinated to one water molecule, three histidines 46, 48 and 120, and shares
94-

an imidazolate ring histidine 63 with the Zn
aspartic acid and two histidines, 71 and 80.
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94-

In addition, the Zn is coordinated to one

In the absence of metals, SOD1 is in the immature, apoprotein state. The
disulfide-reduced apo-form of SOD1 is considered to be the best substrate to enter into
the mitochondria, but it is the form most prone to aggregation (Furukawa et al., 2004). In
the apoprotein, loop IV, which is involved in the dimerization, and loop VII, the
electrostatic loop, become highly disordered and flexible. Under these conditions the two
p-sheets look like an "open clam", and the buried zinc site becomes solvent exposed.
Subsequently, Zn2+ can be added to the immature, reduced form of the enzyme, restoring
order to the two loops (Banci et al., 2003) and inducing the dimeric state (Arnesano et al.,
2004). Recent findings have shown that upon the addition of just one zinc ion to the
homodimer, the two loops become ordered, and possible communication between the two
subunits occurs through contact between the zinc loop and the dimer interface (Potter et
al., 2007). However, if the "open clam" configuration should occur in the monomelic
species, then the edge (3-strands 5 and 6 of one monomer could interact with the edge
strands of another monomer, leading to nonproductive protein-protein interactions
(Valentine and Hart, 2003) such as those observed in fibril formation in ALS patients
(Stathopulos et al., 2003). It has been shown that the loss of metal ions in mutant SODls
significantly decreases the thermodynamic stability of the enzyme and leads to a partial
unfolding transition and possibly misfolding and aggregation of the apo-SODl
(Stathopulos et al, 2003; Lynch et al., 2004; Banci et al, 2008). In the case of A4V apoSODl, hydrogen exchange monitored by mass spectroscopy showed that the mutant was
destabilized at the dimer contact at residues 50-53 and throughout residues 21-53, which
consist of p3, p4, loop II and III (Rodriguez et al., 2005; Shaw et al., 2006). These
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findings were in line with the various reports indicating that A4V apo-SODl aggregated
by perturbing the dimer interface (Khare et al., 2004; Rakhit et al., 2004; Ray et al.,
2004). Furthermore, differential scanning calorimetry (DSC) studies showed that A4V
apo-SODl was considerable less stable than WT apo-SODl (Rodriguez et al., 2005).

1.3.2

Role of the Cysteine Residues
There are four cysteine residues in the hSODl proteins at positions 6, 57, 111 and

146. Cys57 and Cys146 form an intracellular disulfide bond (Tiwari and Hayward, 2003).
This bond is a rare feature for an intracellular protein located in a highly reducing
environment such as the cytosol (Hwang et al., 1992). When the disulfide bond is
formed, it causes a shift in the monomer-dimer equilibrium favoring the dimeric species.
Also, it is kinetically stable and, together with the metal ions, contributes to the stability
of the enzyme (Arnesano et al., 2004; Furukawa et al., 2004). Hence, when the bond
between Cys57 and Cys

is reduced, loop IV becomes disordered and destabilizes part of

the p-barrel, the dimer interface and the zinc-binding site. This could lead to loss of
dimerization as well as metal ions, followed by partial unfolding. Indeed, mutant
proteins are more susceptible to disulfide reduction and monomerization than the wildtype protein (Arnesano et al., 2004). Recently, it was suggested that Cys57 and Cys146
might play a role in protein aggregation by forming intermolecular disulfide bonds (Deng
et al., 2006).
As for the other two-cysteine residues, Cys6 is located inside the P-barrel where it
is solvent inaccessible and Cys111 is solvent exposed and positioned near the dimer
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interface (Tiwari and Hayward, 2003). From aggregation studies, it was observed that
these two cysteine residues most likely form bonds within the fibrous aggregate and
increase the severity of aggregation (DiDonato et al., 2003; Banci et al., 2007) (Figure 4).
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Figure 4. Crystal structure of human SOD1 (figure from PDB, ID 1SPD). The cysteines
are represented in yellow, and the coordinated metals are shown in green for copper and
gray for zinc.

1.4

Function of the SOD1 Protein
Cu/Zn SOD is an antioxidant enzyme found mainly in the cytosol, nucleus, and

mitochondrial intermembrane space of eukaryotic cells and in the periplasmic space of
bacteria (Valentine et al., 2005). This enzyme has been shown to play a protective role in
cells against oxidative stress by catalyzing the disproportionation of superoxide anion
into O2 and H2O2. This reaction occurs through the alternate reduction and oxidation of
the active site copper ion. This catalysis is a two-step process (Fridovich, 1995):
Reaction 1: 0 - 2 + C u 2 + Z n S O D l

0 2 + Cu+ZnSODl

Reaction 2: 0

H 2 0 2 + Cu2+ZnSODl

2

+ 2H+ + Cu+ZnSODl
Cu/ZnSODl

N e t reaction: 2 0 2 + 2H+ ~^-~~~~~~-
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02 + H202

In the oxidized form, Cu has irregular five-coordinate geometry, and in the
reduced form its configuration assumes nearly trigonal planar three-coordination
geometry. From the crystal structure of the reduced form, it was shown that Cu+ moves
1.3 A away from His63, which becomes protonated, and releases the water ligand. Zn2+
has a tetrahedral geometry (Valentine et al., 2005).
To reach the copper ion, the superoxide anion is guided electrostatically through a
positively charged, narrow channel (Cudd and Fridovich, 1982). The active-site channel
with its bound metal ions is formed between the electrostatic loop VII and loop IV (Parge
et al., 1992). Both steps of the reaction occur with a diffusion-controlled rate constant of
2 x 109 M" s" , and each reaction step is pH-independent over the range of 5- 9.5 (KlungRothetal, 1973).
1.5

Amyotrophic Lateral Sclerosis (ALS)- the Disease
FALS-linked mutations have been found in every major structural element in the

dimeric enzyme such as the P-barrel, loop regions, disulfide bond, copper and zinc
binding sites and the dimer interface region (Cleveland and Rothstein, 2001). The
majority of these mutations are point mutations in the DNA that cause amino acid
substitutions, deletions, or insertions that lead to frameshifts and truncations (Valentine et
al., 2005). ALS mutant SOD1 proteins fall into two categories depending on their metal
content, SOD activity and spectroscopic characteristics. The first category is known as
"wild type-like" (WTL) mutants for which the activity and spectroscopic characteristics
of the mutant SOD1 are similar to those of wild-type (WT) SOD1. The second category
is comprised of the "metal-binding-region" (MBR) mutants. MBR mutants contain lower
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levels of metallation and exhibit different characteristics than the WT SOD1. These
mutations are usually found in the metal binding ligands or in the electrostatic and zinc
loop regions that are involved in metal binding (Valentine and Hart, 2003). Table 1 lists
the 2 categories of FALS mutant SOD1 proteins (Valentine et al., 2005). Now, the
puzzling question is how could all these mutations, regardless of type or location, cause
the same disease in ALS patients?
Table 1. Lists of FALS mutant SOD1 proteins as adapted from Valentine et al., 2005.
The WTL mutants have biophysical characteristics that are close to WT SOD1 protein.
The MBR mutants have different biophysical properties than WT SOD1 protein.

Wild-type-like ( W T L ) mutants

A4V ! G72S |

G93V

j N139K

Metal-binding
region (MBR)
mutants
H46R
H48Q

l_8C3 j L84V i
!

G37R | N86S |
I

E100K

!

L144S

H80R

j A145T

G85R

j
i

D101N

i

!

L38V | D90A j

D101G

| V148G

D124V

G41D ! G93A I

11 l i t "

1 I149T

D125H

G41S i G93R i

R115G

I
I

!
I

I
I

j

S134N

H43R j G93C \ E133Del |

C146R

1

1.5.1

!

t

Gain of a Toxic Function
At this point, it is generally accepted that SOD1 mutations result in a gain, rather

than a loss, of some toxic function. These findings have provided support for this
hypothesis. First, transgenic mice that expressed both the human FALS mutant G93A
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SOD1 and their normal mouse WT SOD1 gene did develop progressive
neurodegeneration despite having higher SOD activity. On the other hand, transgenic
mice that expressed human WT SOD1 plus their normal mouse WT SOD1 gene did not
exhibit ALS symptoms (Gurney et al., 1994), and the SOD1 knock-out mice did not
develop motor neuron disease (Reaume et al., 1996). Also, in some FALS mutant SOD1,
the enzymatic activity was not affected (Borchelt et al., 1994).
Four major hypotheses have been proposed to explain the toxic gain of function:
1) excitotoxic death due to mishandling of glutamate (Cleveland et al., 2000), 2)
neurofilament disorganization leading to axonal strangulation (Hirano et al., 1984), 3)
oligomerization (Kaytor and Warren, 1999; Watanabe et al., 2001; Julien, 2001), and 4)
oxidative damage (Wiedau-Pazos et al., 1996; Roe et al., 2002). The last two hypotheses
have been the main focus of studies of ALS mutant proteins (Rakhit at al., 2002;
Valentine and Hart, 2003; Banci et al., 2008; Meiering 2008). The oligomerization
hypothesis states that ALS mutant SOD1 proteins become misfolded, oligomerize into
high molecular weight species, aggregate with other essential proteins and eventually
become proteinaceous inclusions. It is possible that the intracellular aggregate proteins,
at some point in their formation, become toxic to motor neurons and cause damage to
cellular components and pathways (Valentine and Hart, 2003). Also, it is suggested that
the accumulation of aggregated proteins cause oxidative damage. The oxidative damage
hypothesis proposes that the misfolding of a mutant SOD1 protein modifies the
enzymatic mechanism and allows the protein to catalyze reactions with hydrogen
peroxide or peroxynitrite. In turn, reactive species of nitrogen and oxygen become toxic
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by inflicting damage to proteins by alteration of amino acid side chains, fragmentation of
polypeptide chains, and generation of covalent and noncovalent aggregation (Johnston et
al., 2000). The oxidative damage hypothesis requires copper or some other redox active
metal ion to be involved in the enzymatic activity. However, some evidence has
challenged the validity of the oxidative hypothesis and suggests that the effect of SOD1
mutations in FALS is a result of altered copper chemistry or SOD1 activity
(Subramaniam et al., 2002). On the other hand, there is some evidence of damage in the
tissues of ALS transgenic mice, caused by elevated oxidative stress (Valentine, 2002).
For example, in the G93A mouse, it was found that the mutant CuZnSODl protein itself
was heavily oxidized (Andrus et al, 1998). Also, oxidative stress may be linked to the
accumulation of the unfolded or partially unfolded mutant SOD Is due to decreased
proteasome activity and /or degradation of oxidatively damaged SOD1. This could
overwhelm or impair the cellular chaperone capacity, cause mitochondria dysfunction,
and disrupt other cellular processes (Tiwari and Hayward, 2003). Thus, the oxidative
damage theory cannot be discarded. Nevertheless, in each hypothesis misfolding and
aggregation are linked to toxicity, and the two hypotheses are most likely intertwined
(Valentine and Hart, 2003; Rakhit et al., 2004; Banci et al, 2008) (see Figure. 5).
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Figure 5. Diagram showing the possible steps of oligomerization and their connection
to the oxidative damage hypothesis.

1.5.2

Aggregation Studies
The toxicity of mutant SOD1 could very well be the outcome of aggregation.

Mounting evidence suggests that the aggregation propensity of mutant SOD1 may be the
common denominator for all the different mutations (Lindberg et al., 2002; Khare et al.,
2004; Rakhit et al., 2004). Stathopulos and co-workers (2003) showed by using thermal
studies of various mutant SOD Is that mutations decreased the protein stability and
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increased the unfolding rate. This destabilization increased the propensity of mutants to
aggregate (Wang et al., 2008). As indicated in aggregation studies performed in vitro,
this process is a multistep reaction that consisted of dimer dissociation, apo-monomer
formation followed by aggregation of the monomer species (Khare et al., 2004; Rakhit et
al., 2004; Ray et al, 2004). This process is in equilibrium (Khare et al, 2004):
Dholo <-» 2Mholo <-> 2Mapo —• A (Dholo = holo-dimer, Mholo = holo-monomer,
Mapo = apo-monomer and A = aggregate). Evidence suggests that the dimer is not the
reactive species in aggregation. Instead, the apo-monomer can be a possible intermediate
in aggregation. Next, high molecular weight, insoluble protein complexes (IPCs) appear
as an early event (Johnston et al., 2000). Then late in the disease, aggresomes or
inclusion bodies are formed (Johnston et al., 2000). Inclusion bodies were found in the
cytoplasm of motor neurons in ALS patients and transgenic mice expressing human
FALS linked SOD1 transgene. SOD1 protein was detected in these inclusion bodies,
(Johnston et al., 2000) along with ubiquitin and neurofilament proteins (Valentine and
Hart, 2003). The inclusion bodies were associated with amyloid deposits, which were
fibrils formed by |3- pleated sheets of the protein (Elam et al., 2003).

1.5.3

Mutant Ala 4 Val (A4V)
The A4V mutant is the most common FALS mutation in North America

(Stathopulos et al., 2003). It is associated with the most rapid progression of the disease.
The apo-A4V protein has a significantly decreased thermal stability compared to WT
SOD1 (Rodriguez et al., 2002, 2005), and exhibits an increased susceptibility to disulfide
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reduction (Tiwari and Hayward, 2003). At low protein concentrations, A4V favors the
monomer species and aggregates spontaneously in solution at 37°C (Ray et al., 2004).
This mutation disrupts the dimer interface, which is formed by reciprocal contacts
between the C-terminal (3-strand 8 and residues from the disulfide loop (loop IV). The
main dimer contacts are residues 50-53, 114, 148 and 150-153. Most of the dimer
interface interactions in WT SOD1 are similar in the A4V structure, except at the
mutation site and around the N-terminus. It is found that the structure of the metal sites is
unaffected by the mutation (Hough et al., 2004), but significant structural changes occur
from the increase in volume due to the two additional methyl groups in valine. As a
consequence, some bond lengths change, while others are lost or added. Studies revealed
that side chains of residues Phe20, Leu106, lie113, He149 and lie151, which are near Val4,
shift in a concerted fashion due to steric constraints of the extra two methyl groups on
valine and cause changes in the hydrophobic interactions (Cardoso et al., 2002; Hough et
al., 2004). In WT SOD1, He

has a close, single hydrophobic interaction with Ala with

a bond length of 3.6 A. However in the A4V mutation, He113 moves away from Val4,
loses the close interaction, and makes an additional bond. This change causes lie149 to
shift closer to Val4, and in turn He151 rearranges its position (Hough et al., 2004).
Moreover, the subtle change of Phe20 is associated with the rearrangement of the
important Leu106 that protrudes from the P-barrel (Cardoso et al., 2002). These
observations indicate that there are significant changes in the overall molecular
conformation at the interface, which lead to a different orientation of the two monomers
and to destabilization of the dimer interface. As a consequence of this destabilization, a
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chain of steps would occur: 1) the monomer-dimer equilibrium would favor the monomer
species, 2) subunits would have an increased tendency to lose metal and /or to unfold,
(Cardoso et al., 2002; DiDonato et al., 2003; Hough et al., 2004) and 3) the apo-monomer
species would be produced, as implicated in aggregation (Khare et al., 2004). When the
dimer interface in A4V was stabilized with an engineered intrasubunit disulfide bond,
monomerization and aggregation did not occur. Actually, the new A4V became as stable
as WT (Ray et al., 2004).
In conclusion, the observations presented here about the mutant A4V follow the
general trend that could be a common theme for all or most FALS mutants SOD Is.
Hence, using this mutant in this research might be a good model for detecting probable
intermediate(s) that lead to aggregation.

1.6

Sol-Gel Encapsulation of Proteins
In this research, the sol-gel method is used to entrap the SOD1 in a nanoporous

silica matrix. The advantages and disadvantages of this method are numerous, and the
following list highlights only the relevant ones for this investigation.
Advantages:
•

The sol-gel method may stabilize the encapsulated protein due to the
excluded volume of the silica matrix (Eggers and Valentine, 2001a). The
effects of the excluded volume on the protein's structure in vivo may play
an important role since a large fraction of the available volume in a living
cell is occupied by macromolecules (Minton, 2001).
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•

The sol-gel method allows protein contact with solvents for
conformational studies while preventing protein aggregation.

•

Glass entrapment generally improves the thermal stability of proteins
(Eggers and Valentine, 2001b).

•

The protein is encapsulated in a pore size small enough to prevent
leaching of the biomolecule, but large enough to allow smaller analytes to
enter the matrix.

•

The final material is optically transparent, which makes spectroscopic
measurements possible (Eggers and Valentine, 2001a; Jin and Brennan,
2002).

•

The bovine SOD1 molecule is known to retain its structural integrity and
biological function in silica glasses (Ellerby et al., 1992).

Disadvantages:
•

Possible leaching of the protein molecules out of the pores (Pierre, 2004).
To overcome this problem, surfactants such as poly(ethylene oxide) could
be added to control the pore size (Wei et al., 2002). In this work, protein
leaching did occur, and that will be discussed in section 4.1.1.

•

The protein can be damaged possibly by the electrostatic interaction with
the matrix (Pierre, 2004). Cox and co-workers (2003) used
poly(ethyleneimine) to provide protection to the enzyme lactate oxidase.
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•

Due to the interference of the sol-gel materials in the far-UV, the CD
spectra will be stopped at 200 nm. Any readings beyond the 200 nm
become unreliable due to the high noise to signal ratio.

In general, the sol-gel process involves the transition of a system from a liquid
"sol," mostly colloidal, into a solid phase. The starting materials or precursors used in
the preparation of the sol are usually inorganic metal salts or alkoxysilanes that may have
a metal center or functional groups (Wright and Sommerdijk, 2001). Tetramethoxysilane
(TMOS) is used in this study. A series of chemical reactions occurs that may proceed
simultaneously, starting with hydrolysis, which can be acid or base catalyzed. Then the
condensation and polycondensation reactions, which are responsible for building the SiCh
cage surrounding each biological molecule. Next, gelation occurs such that the mixture
does not pour out of the container if tipped. In this step, links form between silica sol
particles to form a giant spanning cluster. After that, the aging process takes place where
further condensation and polycondensation reactions happen, thus strengthening the
matrix material. Also, during this phase the products of hydrolysis and condensation may
evaporate, i.e., alcohol and water, causing the matrix and pores to shrink. Overall
shrinkage of the material could be up to 85% of the initial volume (Jin and Brennan,
2002; Pierre, 2004). A wet gel can be obtained or a xerogel may be formed by
evaporation. Figure 6 shows the different stages of sol-gel processing.
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Figure 6. Schematic drawing of the sol-gel steps adapted form Jin and Brennan, 2002.
The process begins with hydrolysis, then condensation and polycondensation. Next, the
biomolecules are added. Subsequently, gelation and aging occur. A wet gel or xerogel
can be obtained, depending on the drying conditions.

1.7

Circular Dichroism (CD)
Circular dichroism (CD) spectroscopy is a form of light absorption spectroscopy

that measures the difference in absorbance of right and left circularly polarized light by a
molecule which exhibits absorbance and is structurally asymmetric. Asymmetry occurs
when a molecule is chiral (non-superimposable on its mirror image), non-chiral but
covalently attached to a chiral molecule such as aromatic amino acid side chains, or nonchiral present in an asymmetric environment e.g., a chromophores bound to a protein
(Hammes, 2005). CD is well suited to determine and monitor structural and

22

conformational changes in proteins. The near ultraviolet (UV) region (320-260 nm)
provides information about the tertiary structure of the protein, and the far-UV region
(260-190 nm) gives information regarding its secondary structure (Sreerama and Woody,
2004). The different secondary structures of proteins are alpha helix, parallel and
antiparallel beta sheet, and random coil. Analysis materials have been developed to
characterize components of the secondary structures (Sreerama et al., 1999; Sreerama and
Woody, 2000). CD data are reported in units of absorbance or ellipticity (G). Molar
ellipticity ([0]) is normalized for concentration, and is usually expressed in (deg cm2/
dmol) (Sreerama and Woody, 2004). Before obtaining CD data, pure nitrogen is
circulated in the instrument to purge any oxygen from the system, since oxygen absorbs
light around 200 nm, and interferes with the measurements.
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CHAPTER 2
2.0 Materials and Methods
2.1

Materials
Tris-HCl, methanol, dithiothreitol (DTT), Cu sulfate and Zn

sulfate

heptahydrate were purchased from Sigma. Potassium acetate (KOAc) and HC1 were
bought from Fisher Scientific. Tris (2-carboxyethyl) phosphine hydrochloride (TCEPHC1) was obtained from Hampton Research. Ethylenediaminetetraacetic acid (EDTA)
was purchased from EMScience. Tetramethylorthosilicate 99+ % (TMOS),
trimethoxypropylsilane 96% (propylTriMOS), and tetramethylammonium chloride
(N(CH3)4C1 or TMAC1) were obtained from Aldrich. 2, 2, 2- trifluoroethanol (TFE) was
purchased from Fluka. Plastic cassettes of 1.0 mm were bought from Invitrogen.
Bovine SOD was purchased from OxisResearch. Human SOD was a generous gift from
J. S. Valentine (UCLA) and P. J. Hart (UT Health Science Center, San Antonio). P. J.
Hart donated the mutant A4V. Purified water (Milli Q) was used in all the experiments.

2.2

Preparation of Solutions
Tris buffer, 10 raM, at pH 8.0 and 7.0 were prepared. KOAc buffer at 5 mM, pH

5.5, and at 10 mM, pH 5.7, 5.5 and 4.0 were made. Two different disulfide reducing
agent solutions were prepared: one was 6 mM DTT at pH 5.5, and the other one 40 mM
TCEP at pH 5.5. A salt solution of 1 M N(CH3)4C1 at pH 7.0 was prepared. 100 and 1
mM EDTA were used in conjunction with 10 mM KOAc buffer at pH 4.0 for a final
concentration of 10 and 0.33 mM EDTA respectively. Protein leaching out of the sol-gel
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pores causing loss of the CD signal was a major problem in this work. To circumvent
this issue, sol-gel samples were used immediately after the two weeks of maturation, and
samples were kept at 4°C at all times (except during incubation periods at 37°C or during
testing). As observed in Figure 30, most of the samples had enough protein to give a
good CD signal even after 12 days of incubation (except for the sample incubated in 10
mM Tris buffer at pH 8.0).
A series of TFE solutions was prepared from 15-80% (vol/vol) at pH 5.4. A Zn2+
sulfate and Cu

sulfate stock solution of 0.100 M concentration of each was made and

then diluted with 5 mM KOAc buffer at pH 5.5 to obtain the desired concentration of 20
mM Zn2+ and 20 mM Cu2+ at pH 5.5.
Two different disulfide reducing agents, DTT and TCEP-HC1 were used because
TCEP-HC1 has some advantages over DTT. TCEP-HC1 is odorless, resistant to air
oxidation and is more stable and effective than DTT over a broad range of pH. TCEPHC1 reduces peptides and proteins over a wide range of pH (between 1.5-11.1), salt,
detergent and temperature conditions. Also, TCEP-HC1 is unreactive toward other
functional groups in proteins. Another useful property of TCEP-HC1 is the ability to
dissolve in water resulting in a solution pH ~ 2.5, which could be adjusted to the desired
experimental pH. TCEP-HC1 has about 80% of the reducing capacity intact for 21 days
over a wide range of pH. TCEP-HC1 reduction is rapid when a molar excess is used with
the sample. Furthermore, it can be used with IR and NMR spectroscopy
(http://www.hampton research.com).
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2.3

Standard Sol-gel Preparation
Three 15-ml plastic tubes were used per batch. In each tube the following

reagents were added in this order: 1.00 mL of TMOS, 30.0 uL of 0.040 N HC1 and 214
uL of Milli Q water. The acid catalyst HC1 was added in this step with the precursor
materials to speed up the hydrolysis reactions without denaturing the protein. Next, the
solutions were mixed gently, and then placed in ultrasound sonicator filled with ice /
water for 20 minutes. Afterward, 4.65 mL of aqueous protein / buffer solution was added
to the hydrolysed TMOS mixture of 3.10 mL (determination of protein concentration and
aqueous protein / buffer volume are covered in the next section). At this point the entire
mixture had a volume of 7.75 mL. Next, the mixture was divided in half and
immediately transferred using a plastic pipette into two plastic cassettes. When the
mixtures were solidified, the cassettes were covered with parafilm and placed at 4°C for
24 hours. The next day, the methanol-rich liquid that formed on top of the gel was
drained, a few milliliters of Milli Q water were added, and the cassettes were covered
again with parafilm. The sol-gel mixtures were placed back at 4°C for two weeks to
mature (Ellerby et al., 1992; Eggers and Valentine, 2001a) (see Figure 7).
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TMOS = 1.000 mL
HC1 = 30 uL
H 2 0 = 214 uL

Original protein stock

Per tube = 1.244 mL
X mL original protein stock

Total = per tube x 3
= 3.732 mL

(4.65- X) mL buffer
nil iiiliilBlVTillli-' " ' ~

4.65 mL
(protein + buffer)

3.732 mL
(TMOS +HC1+H20)

Use only 3.10 mL
from this mixture

Figure 7. A schematic drawing describing the standard sol-gel preparation.
After two weeks of aging, the sol-gel sheets were ready to be prepared as
individual samples for experiments. Each silica sheet was cut vertically about every
centimeter with a razor blade to give multiple small wafers that fit into a quartz cuvette
with a 2 mm pathlength, as used in CD analysis. Then, each silica wafer was incubated
in 3.0 mL of the desired buffer or solution at 4 or 37°C for a minimum of 24 hours to
assure the pore volume of the glass has fully equilibrated with the solution (Eggers and
Valentine, 2001a). Next, samples were carefully moved to a cuvette using forceps and
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immersed in their original buffer or solution (unless otherwise specified), and CD spectra
in the far-UV were recorded using the circular dichroism spectrophotometer, AVIV
Model 215. Data were collected from 200 to 260 nm at 25°C unless mentioned
differently. One scan was taken for each sample with an averaging time of 1.0 second,
and the blank control spectrum (buffer only) was subtracted from each scan.
Also, a 10% propyl-modified wet sol-gel was prepared following the same
procedure as above with one exception with the starting materials: 2.650 mL of TMOS
was added to 0.350 mL of propylTriMOS. Then, 1.000 mL of TMOS/ propylTriMOS
mix was added to each of the three 15-mL plastic tubes. The next steps were the same as
the standard sol-gel preparation, procedure and testing given above.

2.4

Protein Concentration
Bovine Cu/Zn SOD (bSODl) was used in this research as a reference. The

protein concentration and stock dilution needed for a good CD signal were determined
using bSODl since its molecular weight and protein concentration were similar to the
WT hSODl and A4V. A 1: 20 dilution of the original protein stock of 10 mg/ml (in 10
mM Tris buffer, pH 7.0) was used since it produced a strong signal with little noise from
the total absorbance. The concentration of bSODl was determined using the UV-Vis
spectrophotometer and by applying the Beer-Lambert law:
A = ex ex 1
Where
•

A is the measured absorbance,
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•

8 (L mol 1 cm1) is the extinction coefficient at some characteristic wavelength,

•

1 (cm) is the pathlength of the cuvette in which the sample is contained,

•

c (L/1 mol) is the concentration of the protein.

The concentration is calculated as follows:
c = (A x dilution factor x MW) / (s x 1)
For the specific case of bSODl:
•

A = 0.143 (measured value obtained from the UV-Vis spectrophotometer),

•

e = 10,300 M"1 cm"1 at 258 nm (value obtained from Roe et al., 1998),

•

1 = 0.200 cm,

•

dilution factor = 20,

•

MW = 32 500 g / mol (OxisResearch); is the molecular weight used to convert
concentration to g / L.

For the specific case of hSODl:
•

A = 0.498 (measured value obtained from the UV-Vis spectrophotometer),

•

8 = 10,800 M"1 cm"1 at 280 nm (value obtained from Rodriguez et al, 2002),

•

1 = 0.200 cm,

•

dilution factor = 20,

•

MW = 32 000 g / mol (Valentine et al., 2005).

To determine how much protein to use in standard sol-gel samples, the following
equation was employed:
(Total volume of sol-gel 7.75 mL) / (20 dilution factor) = 0.39 mL.
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The protein's volume was rounded to 0.40 mL. However, as the protein aged
there was a need to increase the protein's volume to 0.60 mL (0.5 mg/ml or 15.6 uM)
(1/40 is needed in a 2 mm cuvette path, and then 1/20 dilution will be used in a 1 mm
thick glass, as determined by the cassette spacing).
The aqueous protein / buffer solution must have a volume of 4.65 mL. So, if the
protein's volume is 0.60 mL, then the buffer's volume (either Tris, pH 7.0 or KOAc, pH
5.7) must be 4.05 mL by subtraction.

2.5

Converting Raw CD Data to Mean Residue Ellipticity ([0])
Ellipticity values, 9, obtained from the CD instrument in units of mdeg were
9

1

converted to the mean residue molar ellipticity [0] in deg x cm x dmol" by using the
following formula:
[6] = (0 x MW x 100) / (N A x d x 1000 x CM)
[0] = (0 x MW) / (N A x d x 10 x CM)
Where:
•

0 is the measured ellipticity (CD data in mdeg),

•
•

NA is the number of amino acids per protein (153 x 2) for dimer SOD1,
d is the path length in cm (0.1 cm for a glass sample),

•

CM is the molar protein concentration,
o

CM = (c x protein's volume used in sol-gel) / total volume of sol-gel,
where c is the protein stock concentration obtained from the UV-Vis

30

instrument, the protein's volume used in sol-gel is 0.40 or 0.60 ml, and
7.75 mL is the total volume of sol-gel.
•

2.6

Conversion factors:
o

100 is used to convert the molar concentration to dmol x cm"3,

o

1000 is used to convert millidegree to degree.

Addition of Metals to hSODl and A4V
94-

94-

Dilute stock metal solutions of Cu and Zn

sulfate were added to ensure that

the hSODl and A4V were fully metalated. The protein concentration [hSODl] was
estimated as follow: Assume 10 g / L stock protein in 5mM KOAc, pH 5.5. [hSODl] =
(10 g / L x 1000) / (32000 g/ mol) = 0.31 mM. The 1000 factor was used to convert
molarity to a millimolar scale. Next, 30 uL of 20 mM Zn2+ sulfate was added to about
10 g / L of stock solution of hSODl, and was incubated at 4°C for a few hours. Then,
30 u.L of 20 mM Cu2+ sulfate was added to the protein stock solution and incubated at
4°C for a minimum of 24 hours. Since Cu2+ has the tendency to occupy both the zinc and
the copper binding sites, Cu2+ sulfate was added after the incubation with Zn2+ sulfate
(Valentine et al, 1979).

31

CHAPTER 3
3.0 Results
3.1

First Aggregation Condition: Heat
First, the CD spectra of WT SOD1 encapsulated in standard sol-gel was compared

with that of WT in solution at 25°C to determine if any structural change occurred due to
encapsulation. The reference spectrum shown in all of the figures in this document is the
native conformation of encapsulated WT incubated in Tris buffer, pH 7.0, at 2°C.
Similarly, for A4V figures, the reference used is that of the encapsulated A4V protein
under like conditions. The reference of WT and A4V tests in solution is the native WT
and A4V conformation in Tris buffer, pH 7.0, at 25°C. Based on the spectra shown in
Figure 8A, the structural difference that could be attributed to encapsulation is minor
(225-240 nm). While the sol-gel encapsulation process may trap proteins in non-native
conformations as reported with hemoglobin (Khan et al., 2000) and apomyoglobin
(Eggers and Valentine, 2001b), no such conformational changes were observed with WT
orA4VSODl encapsulation.
Next, the effects of heat treatment on the sol-gel encapsulated WT protein were
compared with that of WT in solution. The spectra shown in Figures 8B-E are
remarkably similar, and the major improvement in thermal stability, as reported
previously for other proteins (Eggers and Valentine, 2001a), was not observed in this
case. The secondary structure of the sol-gel encapsulated sample at 85°C (Figure 8F)
appears to be more denatured than the solution structure at 85°C. This may be due to the
fact that solution spectra were taken immediately upon reaching the desired temperature,
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whereas sol-gel samples were equilibrated for about 5 minutes at each temperature before
scanning.

210

220
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Wavelength (nm)

210

220
230
Wavelength (nm)

210

220
230
Wavelength (nm)

Figure 8. (A-I). Thermal denaturation of WT and A4V SOD1 at various temperatures.
(A-F) CD spectra in the far-UV comparing WT SOD1 secondary structure in solution
and in sol-gel at temperatures ranging from 25-85°C. The references shown for WT and
A4V SOD1 are the spectra in solution without encapsulation, in Tris buffer, pH 7.0, at
25°C. (G-I) CD spectra in the far-UV comparing A4V SOD1 secondary structure in
solution and in sol-gel at 25, 37, and 85°C.
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Finally, the effects of heat treatment on the secondary structures of sol-gel
encapsulated WT and A4V proteins are compared (Figure 9). The structure of
encapsulated A4V was found to be extremely sensitive to heat treatment as compared
with WT. The encapsulated A4V sample began to denature at 37°C as compared to 7585°C for the WT (Figures 9B-C and 8G-I). In addition, the A4V sample denatured in
two different structural conformations depending on the applied temperature range. From
37-55°C, A4V conformational changes were different than those in the range of
65- 85°C. The more negative molar ellipticity around 220-240 nm and 202 nm regions,
and the positive trend around 210-215 nm region, suggests that a decreased p-structure
and an increased random coil structure has transpired. Protein damage with heat
treatment in the above range was irreversible for both the WT and A4V. The thermal
stability of the A4V protein was not tested in solution since this mutant is known to
aggregate (Ray et al., 2004).
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Figure 9. Thermal denaturation of SOD 1. CD spectra of SOD 1 in the far-UV showing
the effect of heat from 25-85°C on (A) WT in solution (B) encapsulated WT in sol-gel,
and (C) encapsulated A4V in sol-gel.
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3.2

Second Aggregation Condition: Low pH
The effects of different low pH conditions (pH 4.0 and 5.7) on the secondary

structure of the encapsulated WT and A4V proteins are examined in this section and
compared to the structure at pH 7.0, which is used as a reference.

3.2.1

Encapsulated WT and A4V Proteins in Tris Buffer, pH 7.0
Initial expectations were that the encapsulated WT protein would be rather stable

at pH 7.0. However, several drastic potential intermediate conformational changes were
observed over the two-month test period, most of which occurred on the seventh and 11 th
day of the experiment (Figure 10A). The WT sample was stored at a constant 4°C during
the entire test period, except when the CD measurements were taken at 25°C for short
periods. A change in the secondary structure on the seventh day (Figure 10B) took place
with a negative CD band at around 212 nm. In addition, this conformational change
resulted in the loss of intensity of CD signal for all the tests that followed. This suggests
that the unfolding/refolding process resulted in leaching of some of the encapsulated
protein out of the sol-gel matrix. Furthermore, there is a strong evidence, as will be
discussed in another section of this study, that the negatively charged protein at pH 7.0
(pi ~ 5.8) is repelled by of the negatively charged sol-gel matrix. Moreover, leaching is
dependent on the sol-gel pore size, which may differ for samples prepared with Tris pH
7.0, and pH 5.7 (Hoang and Lee, 1997). Again, this will be discussed in more detail in
Chapter 4, but it is mentioned here mainly to explain why this leaching did not occur with
the A4V sample shown in Figure 10. Hence, in order to compensate for the lower protein
concentration and facilitate comparison with the encapsulated A4V under similar
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conditions, the CD data is normalized to have the same ellipticity value near the
minimum. This is shown in Figures 10B-B' and a similar compensation is performed for
the final measurement on the 54th day (Figures 10C-C). Based on the normalization
factors used for the seventh and 54* day spectra, approximately 40% of the protein was
lost after the seventh day, and an additional 10% was lost over the rest of the test period
( l l l - 54l days). It is important to note that the odd measurement taken on the seventh
day cannot be due to protein leaching out of the sol-gel matrix since the CD signal
intensity on the ninth and 1 l l days are more negative in the 200-220 nm region (Figure
10A). Thus, the CD data normalization shown in Figure 10-B' is performed mainly to
highlight the remarkable similarity with the final A4V conformation in Figure 10E.
Given that other odd measurements similar to the one observed on the seventh day are
also noticed under different test conditions, this conformation could be a potential
transient intermediate or simply an artifact. The possible causes are discussed in Chapter
4.
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Protein's conformations
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Figure 10. CD spectra in the far-UV of encapsulated SOD1 incubated in Tris buffer, pH
7.0. WT sample equilibrated (A) for 1, 2, 3, 7, 9, 11 and 54 days, (B) for 1, 2, 3, and 7
days, (B') compensation for signal in day 7 as observed in A and B, (C) incubation after
54 days and ( C ) compensation for signal in (C). (D) A4V sample equilibrated for 2, 4
and 54 days, and (E) after 54 days.
With the encapsulated A4V protein, a similar conformation to the one
encountered with WT (seventh day) was observed, but the major difference is that the
A4V protein did not refold to the native conformation even after 54 days (Figures 10B'
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and E). In addition, the encapsulated A4V did not leach out of the sol-gel (i.e., no loss of
signal was encountered) under identical test conditions used with WT except for the solgel samples being prepared with slightly different methods (pH 7.0 vs. pH 5.7). This
suggests that the A4V conformational changes were different as compared with the WT,
but more importantly that these changes were irreversible. By comparing the spectra
shown in Figures 10B'-C and Figure 10E, the final A4V conformational change was
obviously more similar to the possible transient intermediate WT change that took place
on the seventh day, as compared to the final WT conformation. The positive CD signal
in the 225-235 nm region could be attributed to either disulfides or aromatic side chains
(Sreerama and Woody, 2004). Even though aromatic side chains affect the CD signal
significantly in the above region, especially for proteins with low a-helix content
(Sreerama and Woody, 2004), it is suspected that the disulfide bonds are the major
contributors in this case in spite of the fact that SOD1 protein has less than 7% a-helix
content. This is based on other tests shown in section 3.4 that specifically target the
disulfide bonds (i.e., addition of TCEP/DTT). It is important to note that the
encapsulated A4V protein showed a significant dip in the 225-235 nm region (i.e., more
negative ellipticity) in all of the other test conditions except for this one. This region
(225-235 nm) was unaffected even after 54 days of incubation at pH 7.0, but the entire
CD spectrum appeared to be slightly red-shifted as a result. Finally, this region was more
positive for A4V SOD1 as compared with WT SOD1 in both solution and sol-gel
encapsulated measurements.

38

3.2.2

Encapsulated WT and A4V Proteins in KOAc Buffer, pH 5.7
The WT protein was encapsulated in two different standard sol-gel batches. In

the first batch, KOAc buffer, pH 5.7, was used as the aqueous protein / buffer component
during the sol-gel preparation, and in the second batch, Tris buffer at pH 7.0 was used.
The protein stock and concentration used for both sol-gel batches was identical.
From the first batch (prepared with pH 5.7 buffer), a WT sample was incubated in
KOAc buffer, pH 5.7, for 54 days at 4°C, and CD measurements were taken periodically.
Figures 11A-C show all the conformational changes observed with this sample. The
most notable change in the secondary structure occurred on the third day, which indicates
less content of P-structure (Hornemann and Glockshuber, 1998; Sreerama and Woody,
2004; Fujiwara et al., 2005) with the characteristic 215 run signal intensity change
(Figure 1 IB). On the seventh day the P-structure content becomes close to the native
structure. After 54 days of incubation the conformation has a more negative value at the
minimum near 209 ran than the native structure (Figure 11C).
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Figure 11. CD spectra in the far-UV of encapsulated WT SOD1 in two different sol-gel
batches. A sol-gel sample prepared with KOAc buffer, pH 5.7, incubated in KOAc, pH
5.7, at 4°C is represented from (A-C); (A) incubation for 1, 2, 3, 7, 9, 11 and 54 days,
(B) for 3, 7, 9 and (C) 54 days. A sol-gel sample prepared with Tris buffer, pH 7.0,
incubated in KOAc, pH 5.7, at 4°C is described from (D-E); (D) incubation for 1, 2, 3,
7, 9, 1 land 54 days, (E) for 7 and (F) 54 days.

Surprisingly, the WT sample from the second batch (prepared with Tris, pH 7.0)
demonstrated a completely different behavior under identical conditions (Figures 11D-F).
None of the interesting potential transient intermediates that were observed with the other
batch occurred with this sample. As will be discussed in Chapter 4, this is most likely
due to the pore size difference of the sol-gel samples prepared with pH 7.0 and pH 5.7.
Nonetheless, after 54 days of incubation, the change that occurred in the region between
200-210 nm (Figure 1 IF) suggested that the metals might have been released. To test
this hypothesis, additional measurements were conducted on the same sample, where Zn
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and Cu ions were added (Figures 12A-B). While the addition of Zn ion caused a
significant transformation in the secondary structure, the addition of Cu ion did not result
in any changes in the conformation. Recently, Potter and co-workers reported similar
results with the addition of Zn ion to the apoprotein in solution (Potter et al., 2007). After
metal addition, the sample was placed back in KOAc, pH 5.7, for 28 days, and the final
conformation that resulted was a near-native structure with a decrease in the negative
ellipticity in the region between 205-215 nm (Figure 12C). Finally, the same sample was
put in KOAc, pH 4.0, to destabilize the native fold (Chitin et al., 2002). After one day of
incubation in pH 4.0 at 4°C, no major change was observed, but, after only 10 minutes of
incubation at 37°C, a notable change in the 200-215 nm region was detected (Figures
12D-E). The sample was then incubated at 37°C for longer periods resulting in a drastic
change in the secondary structure (200-210 nm and 225-235 nm) (Figure 12F). This
spectrum suggests that the protein's structure is largely unfolded at this stage. The dip in
the 225-235 nm region is likely to be due to breaking the disulfides, to be discussed
further in section 3.4. After another 20 days of incubation at 4°C in pH 4.0, the WT
SOD1 appeared to regain structure, but the final conformation was a non-native structure
(Figure 12G). It seems that the destabilization to the protein structure and the associated
unfolding was partially reversible, unlike the temperature effects that were found to be
irreversible. The WT SOD1 protein has shown an impressive tendency to fold and refold
after partial unfolding under the effect of low pH at 37°C. This is in striking contrast to
the A4V protein, as will be discussed in later sections.
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Figure 12. CD spectra in the far-UV of encapsulated WT SOD1 under various
conditions. (A) In KOAc, pH 5.7, for 54 days followed by Zn ion for 1 and 4 days, then
Cu ion for one day, and then in KOAc, pH 5.7. (B) Addition of Zn ion for 4 days. (C)
Incubation in KOAc, pH 5.7 for 28 days after the addition of Zn ion. (D) Equilibration
in KOAc, pH 5.7, for 28 days was followed by incubation in KOAc, pH 4.0, for one day
at 4°C, 10 minutes, and 3 days at 37°C, then 1 day at 4°C, another day at 37°C, and 20
days at 4°C, (E) effect of KOAc, pH 4.0, at 37°C for 10 minutes, (F) in pH 4.0, for one
day at 37°C, and (G) the final conformation after 20 days in KOAc, pH 4.0, at 4°C.

Since none of the measurements that were observed with the second batch (sol-gel
prepared with pH 7.0) showed the possible transient intermediates observed with the first
batch (sol-gel prepared with pH 5.7), additional tests were conducted on the first batch
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(pH 5.7). The same sample that was used previously (54 days in pH 5.7) was subjected to
other conditions to see if the previously observed potential transients could be
reproduced. The sample was first placed in Tris buffer, pH 7.0, and then changed to 40
mM TCEP. No CD spectrum was obtained due to the magnitude of noise caused by the
high absorbance of TCEP. Consequently, the sample was placed in Tris buffer, pH 7.0,
for 2 days at 4°C, and then a measurable CD signal was obtained. The conformational
changes that resulted are shown in Figures 13A-B. The change in the secondary structure
(Figure 13B) is close to that observed on the third day with the original sample (Figure
1 IB), however the protein leached out of the sol-gel matrix as shown in the following
measurements (Figures 13C-D). In order to facilitate comparison with other
measurements, the spectra were multiplied by a compensation factor as described
previously to normalize the results (Figures 13C-D'). The final conformation indicates
that the protein did fold back to the native conformation, and the dip in the range between
200-208 nm is perhaps the result of releasing the metal in the process (by comparison to
the apoprotein spectrum). EDTA was added at the end of this experiment but produced
no further effects, suggesting that the metal had already been released in a previous step.
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Figure 13. CD spectra in the far-UV of encapsulated WT SOD1 incubated in various
buffers. (A) In KOAc at pH 5.7 for 54 days followed by Tris buffer, pH 7.0, after 1 day
in TCEP, then another 6 days in Tris, pH 7.0, then placed back in KOAc, pH 5.7, for 2
days, and finally in 30 mM EDTA for 6 days, (B) in Tris, pH 7.0, after 1 day in TCEP,
(C) followed by Tris, pH 7.0, for 6 days, KOAc, pH 5.7, for 2 days, and in 30 mM
EDTA for 6 days; ( C ) compensation for protein loss in (C), (D) CD WT protein in 30
mM EDTA for 6 days and (D') compensation for protein loss in (D).

Based on the results obtained with WT, A4V protein was encapsulated in the
standard sol-gel made with KOAc buffer, pH 5.7. After one day of incubation at 4°C,
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there was a noticeable difference in the starting point of the A4V spectrum relative to the
solution spectrum with an increase in negative ellipticity between 220-250 nra as shown
in Figures 14A-B. Another A4V sample was tested to confirm the change in the
secondary structure, and the new sample produced identical results (Figures 14C-E).
Then, Zn2+ was added to determine if the dip between the region 250-220 nm is related to
metal loss (Figure 14D), but no major change was observed. It is important to note that
no potential transient intermediates with P-characteristics were detected with the mutant
A4V protein in pH 5.7 or 7.0, as previously was shown with the WT protein.
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Figure 14. CD spectra in the far-UV of encapsulated A4V SOD1 incubated in various
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3.2.3

Encapsulated WT and A4V Proteins in KOAc Buffer, pH 4.0
This section focuses on the destabilization effect of low pH on the secondary

structure of WT and A4V SOD1. Four WT samples were used; three of which where
encapsulated in sol-gel made with KOAc, pH 5.7, and the fourth was encapsulated in solgel made with Tris, pH 7.0.
The first WT sample (sol-gel made with pH 5.7) was incubated in 10 mM KOAc
buffer, pH 4.0, at 4°C for 54 days (Figures 15A-C). Most of the observed structural
changes occurred in the 200-210 nm region, but none of the p-characteristics that were
observed with pH 5.7 were encountered (Figures 1 IB and 13B). After 54 days, there was
an increase in the negative ellipticity between 200-210 nm and a minor change in 228230 nm region indicating a slight destabilization of the protein. Since the secondary
structure was stable at 4°C, a different approach was needed to perturb the structure and
trap any intermediate conformations.
The second WT sample (sol-gel made with pH 5.7) was initially incubated in pH
4.0 at 37°C for 40 minutes to accelerate the destabilization, and then it was placed back at
4°C (Figure 15D-F). After one day at 4°C, a significant change was detected in the CD
spectrum in the region between 200-210 nm (Figure 15E), and the signal resembled the
apoprotein spectrum in solution (Potter et al., 2007). Thus it was assumed that metal loss
occurred. After four days, further changes were detected in the region between 200-210
nm as well as 225-235 nm (Figure 15E). The sample was left in the same condition (at
4°C) for six additional days, and the final conformation on the 10th day (Figure 15F)
shows that the WT protein reverted to a conformation somewhat resembling the reference
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except for the dip in the region between 200-210 nm. In addition, the recovery in the
region between 228-230 nm was rarely observed with WT protein and never with the
A4V mutant.
The third WT sample (sol-gel made with pH 5.7) was incubated in KOAc, pH 4.0,
at 37°C for multiple days. The protein adopted a random coil structure after just one day
of incubation (Figure 15H). After four days, the structure unfolded completely (Figure
151). Increasing the temperature from 4 to 37°C at pH 4.0 had a devastating effect on the
stability and integrity of the WT structure.
Finally, the fourth WT sample (sol-gel made with pH 7.0) was incubated in
KOAc, pH 4.0, at 4°C for 7 days (Figures 15J-L). After seven-day incubation, the
protein signal resembles the WT sample encapsulated in sol-gel made with pH 5.7 under
identical test conditions (KOAc, pH 4, at 4°C).
It may be worthwhile to note that with pH 4.0, no potential transient intermediates
or folding/refolding of the protein were observed as compared with Tris, pH 7.0 and
KOAc, pH 5.7. The main effect of lowering the pH to 4.0 is to destabilize the protein's
native fold, which is a necessary process to begin aggregation (Chiti et al., 2002). This
pH-induced unfolding is irreversible in the glass matrix if the temperature is raised to
37°C.
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Figure 15. CD spectra in the far-UV of encapsulated WT SOD1 incubated in KOAc, pH
4.0. (A) The first sample was incubated at 4°C for 45 days, (B) day 1, 2 and 9 and (C)
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Two encapsulated A4V protein samples (sol-gel made with pH 5.7) were
subjected to similar condition as the WT samples (10 mM KOAc buffer, pH 4.0, at 4 °C)
for 28 and 20 days, respectively. The results were radically different than those observed
with the WT samples.
The first A4V sample was incubated at 4°C for a total of 28 days (Figures 16AC). After just one day of incubation, an increased negative ellipticity was observed in the
spectrum region between 200-210 nm (Figure 16B). This change was more pronounced
and slightly different than with the WT protein after two days at pH 4.0. Also, after two
days of incubation, a drastic loss of the prominent ellipticity band at 230 nm was
observed. This loss was common to the A4V protein under different aggregation
conditions. Further unfolding continued after seven days, and then the structure became
random coil after 28 days (Figure 16C).
The second A4V sample was subjected to low pH as above, but at 37°C (Figures
16 D-F). Initially the sample was incubated at 4°C for three days, which resulted in a
similar destabilization as above. Consequently, the sample was subjected to heat
treatment. After just 10 minutes at 37°C, there was a major impact on the secondary
structure, and after 3 days at 37°C the protein was fully unfolded (Figure 16 E). The
sample was then incubated for an additional 20 days at 4°C to see if the protein will
attempt to refold, but the damage was irreversible (Figure 16 F).
The data suggests that the mutant A4V is very susceptible to irreversible
unfolding in an acidic environment even at a low temperature, 4°C. Therefore, the use of
less harsh conditions such as pH 5.7 and 7.0 might be able to slow down the unfolding
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process in an attempt to detect any possible intermediates that might have been missed at
pH 4.0.
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Figure 16. CD spectra in the far-UV of encapsulated A4V SOD1 incubated in KOAc,
pH 4.0. (A) The first sample for 28 days at 4°C, (B) 1, 2, 7 and (C) 28 days. (D). The
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followed by 10 minutes and 3 days at 37°C and (F) 20 days at 4°C.

3.3

Third Aggregation Condition: Removing Metals with EDTA
Since apo-SODl has been implicated in aggregation studies performed in vitro,

understanding the behavior and structural changes of the apoprotein or the conditions that
might lead to metal loss could shed some light on its possible role in aggregation. To this
end, both WT and A4V proteins were equilibrated in EDTA at 4 and 37°C. All samples
incubated in 10 mM EDTA exhibited a very high ratio of noise to signal in the far-UV
CD spectrum thus making analysis of the data impossible. To solve this problem, the
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samples were washed with purified water and incubated in 10 mM Tris buffer at pH 7.0
for about 30 minutes prior to testing in order to dilute the EDTA concentration and
decrease the noise. This process does not affect the results because metal chelation by
EDTA should have been complete after being equilibrated for 24 hours (Eggers and
Valentine, 2001a).
A sol-gel encapsulated WT sample made with KOAc, pH 5.7, exhibited a
potential transient intermediate conformation at 215 nm after two days of incubation in
10 mM EDTA, and then the protein reverted to the native conformation (Figures 17A-C).
Interestingly, from the CD spectra there was no indication that an apoprotein was
obtained during those three days, i.e., there was no detection of an increased negative
ellipticity in the region between 200-207 nm.
On the other hand, WT encapsulation in a sol-gel made with Tris, pH 7.0 did
show possible metal loss (Figure 17E) after seven days in 10 mM EDTA. The CD
spectrum showed an increased negative ellipticity in the region between 200-210 nm that
suggested the formation of apoprotein. However, with the loss of metals, further
destabilization of the native structure was expected to occur, but that was not the case.
After 54 days, the CD signal resembled the reference with a near-native like
conformation, but the signal in the 200-207 nm region was unusual (unlike native
conformation or apoprotein). To determine if this was due to metal loss, Zn2+ was added
after rinsing the glass to remove EDTA (Figures 17G-I). Even though, after the first day
of adding Zn2+, there was an apparent change in the CD spectrum, after the fourth day
there was no significant change from the initial condition. Cu2+ was added next, even
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though there is no direct evidence implicating its role in the structural stability. Again,
no change was detected (Figure 17G). It is possible that with this altered near-native
conformation, the Zn2+ could not be added, or a permanent damage occurred in the zinc9+

binding site, or the Zn was added in a different region of the protein. Thus, the sample
was placed back in EDTA and monitored for a long time (72 days) to determine which of
the above possibilities is most likely. Given the lack of additional conformational
changes (Figures 17H-I), the possibility of the zinc ion binding to a different location can
be ruled out.
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Figure 17. CD spectra in the far-UV of encapsulated WT SOD1 protein equilibrated in
10 mM EDTA at 4°C. (A) The first sample at day 1, 2 and 3; (B) at day 2 and (C) day 3.
(D) The second sample incubated for 54 days, (E) day 1, 2, 3, 7 and (F) 54; (G) after 54
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then placed back in 10 mM EDTA for 72 days; (H) the addition of Zn ion for 1 and 4
days after incubation in 10 mM EDTA for 54 days, and then (I) the sample was placed
back in 10 mM EDTA for 72 days.

Since the use of 10 mM EDTA interfered in the CD readings, to circumvent this
problem a lower concentration of 0.33 mM determined by trials (protein concentration
for the entire cassette was 0.5 mg/ml) was used in the following tests (Figures 18A-C).
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After 10 days of incubation, the WT structure began to lose its native configuration
accompanied by a decrease in negative ellipticity between the region 220-230 ran and
207-200 nm, which indicated metal loss (Figure 18C). When the incubation temperature
was increased to 37°C, a change in the spectrum was observed after one day of
incubation (Figures 18D-E). After two days, metal loss was observed (Figure 18E). After
four days, metal loss appeared to be complete, as indicated by the loss in the secondary
structure relative to the metallation reference spectrum in Potter and co-workers (2007)
(Figure 18F).
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Encapsulated A4V protein that was incubated in 10 mM EDTA at 4°C showed an
increased negative ellipticity in the region between 225-240 ran and 200-220 run (Figures
9+

19A-B). To confirm the possibility of metal loss, Zn was added after removal of
EDTA, and a corresponding change was detected in the 200-220 nm region (Figure 19B).
When the sample was placed back in EDTA, a corresponding change was observed in the
94-

same region (Figure 19C). These changes suggest that the Zn was added to the apoA4V protein. However, the changes in the structure did not agree with the work of Potter
and co-workers (2007) done in solution on apo-WT protein. Most likely mismetallation
happened in the mutant A4V SOD1 because of the abnormalities in the metal-binding
properties of the zinc-binding site due to the mutation (Valentine et al., 2005). It is
important to note that changes in the CD signal observed between 225-240 nm were also
encountered with other A4V signals under various conditions such as pH 4.0 and 5.7, and
that the addition of metal does not have effects on that part of the spectrum.
Another A4V sample was used to confirm the demetallation effect under milder
conditions (0.33 mM EDTA). After five days of incubation in 0.33 mM EDTA, a
significant change was observed in the CD regions between 225-240 nm and 200-220 nm
(Figures 19D-E). Then the temperature was raised to 37°C for 10 minutes, and the
sample was measured. Next, the same sample was again incubated at 37°C for two
consecutive 15-minute periods, and readings were obtained. The corresponding change
in the secondary structure (Figure 19E) shows that the initial 10-minute period did most
of the damage (increase in the negative ellipticity in the above mentioned regions). The
complete unfolding of the structure took place after 28 days at 4°C (Figure 19F). These
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observations also suggest the presence of apo-A4V protein. Finally, subjecting the
encapsulated A4V sample to one day at 37°C in the presence of 0.33 mM EDTA
produced irreversible unfolding of the secondary structure (Figures 19G-H).
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Figure 19. Legend:
(A) The first sample was incubated in 10 mM EDTA at 4°C for 2 and 12 days followed
by addition of Zn ion for 1 and 7 days then placed back in 10 mM EDTA for 29 days,
(B) effect of Zn ion after 1 and 7 days on the CD signal of A4V protein incubated in 10
mM EDTA for 12 days, (C) after 29 days in 10 mM EDTA at 4°C. (D) The second
sample incubated in 0.33 mM EDTA for 1 and 5 days at 4°C followed by 10, 15 and 15
minutes at 37°C, and then for 28 days at 4°C, (E) effect of temperature was monitored
after 1 and 5 days at 4°C, then at 10, 15 and 15 minutes at 37°C and (F) after 28 days at
4°C. (G) The third sample was placed in 0.33 mM EDTA at 37°C for 1 day, then at 4°C
for 2, 6, 28, and (H) 28 days.

3.4

Fourth Aggregation Condition: Reducing the Disulfide Bond Using DTT or
TCEP
Two reducing agents were used, namely DTT and TCEP, to characterize the

effect of disulfide bond reduction on both the WT and A4V proteins. Literature reports
provided contradicting results: Arnesano and co-workers (2004) stated that reducing the
disulfide bond should have no effect on the secondary structure of WT protein; however
Fujiwara et al. (2005) showed some loss of the structure using CD. It is expected that
upon reducing the disulfide bond a general destabilization of the secondary structure
would occur. In this work, it was found that slight variations in the test conditions
influenced the secondary structure of the encapsulated reduced SOD1. The effects of
TCEP are studied first, followed by DTT. The samples incubated in 40 mM TCEP and 6
mM DTT were washed with purified water and incubated in 10 mM Tris buffer at pH 7.0
for about 30 minutes prior to testing in order to decrease the noise level.
Initially, a WT SOD1 sample was reduced using 40 mM TCEP, pH 5.5, and
stored at 4°C (Figures 20A-C). The results seemed to agree with Arnesano and
colleagues (2004). There was a minor change in the 200-205 nm range, which was not
significant enough to justify a new finding. On the other hand, when reduction took
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place at 37°C, the WT protein unfolded within one day of incubation (Figures 20D, E). It
seems that increasing the temperature enabled the structural changes in reduced WT
protein. In addition, when two other older samples, previously used to study the longterm effects of pH 5.7 and pH 4.0, were subjected to TCEP treatment, major secondary
structural changes were noticed in Figures 20F-H and Figures 20I-K, respectively. The
reduced secondary structure under the effect of pH 4.0 became more random coil.
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Figure 20, CD spectra in the far-UV of encapsulated WT SOD1 as a function of TCEP
treatment. See legend on the following page.
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Figure 20. Legend:
(A) The first sample was incubated in 40 mM TCEP at 4°C and reading were obtained
for 1, 2, 3, 4 and 10 days; (B) 2 and 4 days and (C) 10 days. (D) The second sample was
incubated at 37°C, and readings were monitored for 4 consecutive days with (E)
showing day 4. (F) The third sample was previously in KOAc at pH 5.7 for 54 days at
4°C, and reduced with 40 mM TCEP for 1 day, then placed in KOAc, pH 5.7 for 2 days,
put in Tris, pH 7.0, for 6 days and then placed back in KOAc, pH 5.7 for 2 days; (G)
reduced WT protein in KOAc, pH 5.7, for 2 days; (H) effect of KOAc, pH 5.7, for 2
days after incubation in Tris, pH 7.0, for 6 days. (I) The fourth sample previously placed
in KOAc, pH 4.0, for 54 days at 4°C, was reduced with 40 mM TCEP for 1 day and
then put in Tris, pH 7.0, for 2 and 6 days, and finally incubated in KOAc, pH 4.0, for 6
days; (J) in KOAc at pH 4.0 for 54 days, then placed in Tris at pH 7.0 for 2 days after 1
day in 40 mM TCEP, then left in Tris, pH 7.0 for 6 days, and (K) placed in KOAc, pH
4.0 for 6 days.

To study the effects of DTT on the secondary structure, three WT samples
encapsulated in sol-gel made with KOAc, pH 5.7, were reduced with 6 mM DTT, pH 5.5,
and stored at 4°C. Then, each sample was washed with purified water and then placed in
a different buffer, at pH 7.0, 5.7 and 4.0, to monitor the effect on the secondary structure
(Figures 21 A-1). In buffer of physiological pH, the reduced WT protein maintained the
native structure (Figures 21A-C). Also, in pH 5.7 buffer, no major changes occurred in
the secondary structure (Figures 21D-F). However, at pH 4.0 the reduced WT protein
went through a conformational change, exhibiting a CD signal around 215 nra that is
reminiscent of a p-structure. After two weeks, the protein refolded to an altered
conformation similar to the reference, but with a major difference in the CD region
between 210-200 nm (Figures 21G-I). It is important to note that the previous oxidized
WT samples that were subjected to pH 4.0 at 4°C did not show the major structural
change in the reduced WT sample shown in Figure 21H. This suggests that even though
reducing the disulfide bond did not produce an apparent change in the secondary
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structure, something else may have changed in order for the reduced protein to produce
different results when placed in pH 4.0. Perhaps future studies could investigate these
further using techniques other than far-UV CD that was solely used in this study. One
possible method could be a fluorescent quenching technique to study modifications in the
protein conformation (Pierre, 2004).
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Figure 21. Legend:
(A) The first sample was in 6mM DTT for 2 days, then in Tris, pH 7.0, for 4 days; (B)
showing spectrum in 6 raM DTT for 2 days and (C) in Tris, pH 7.0, for 4 days. (D) The
second sample was in 6 mM DTT for 2 days followed by KOAc, pH 5.7, for 4 and 18
days; (E) in 6 mM DTT for 2 days, and (F) in KOAc, pH 5.7, for 18 days. (G) The third
sample was in 6 mM DTT for 2 days followed by KOAc, pH 4.0, for 4 and 18 days; (H)
in KOAc, pH 4.0 for 4 days, and (I) for 18 days.

Next, the effects of TCEP on encapsulated A4V protein were investigated. Three
samples were used. Two samples were treated with TCEP first, and then put in different
buffers, one in Tris, pH 7.0, and the other in KOAc, pH 5.7. The third sample was
initially placed in KOAc, pH 4.0, and then treated with EDTA. The TCEP concentration
was 40 mM at pH 5.5 for all the samples.
The samples that were initially treated with TCEP showed a similar
destabilization to the secondary structure (Figure 22). Also, the subsequent pH condition
at pH 4.0 did show additional deterioration indicating a possible metal loss. To confirm
this, EDTA was added to the sample that was in pH 4.0 (Figures 22G-I), and the resulting
signal (Figure 22H) was nearly identical, thus confirming that the metal loss occurred in a
prior step. This loss of metals could be a consequence of the destabilization in the A4V
protein due to the mutation, even though Hough and co-workers indicated that the metal
binding sites were unaffected by the mutation (Hough et al., 2004). However due to the
destabilization in the dimer interface caused by the mutation of alanine to valine,
unfolding or metal loss in vivo may result (Hough et al., 2004). Finally, the A4V protein
unfolded (Figures 22G-I) after seven days at pH 4. This unfolding was irreversible since
the sample was monitored for an additional 16 days with no change in the structure.
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The third sample that was initially placed in pH 5.7, then in TCEP, showed
similar initial deterioration, but after five days in TCEP, the metal loss was not observed,
although the protein fully unfolded after 29 days in TCEP (Figures 22D-F).
Finally it is important to note that the encapsulated oxidized A4V protein
incubated in pH 7.0 buffer did not exhibit similar changes in the secondary structure,
even after 54 days of incubation (Figure 10E), as compared to the reduced encapsulated
A4V protein in pH 7.0 (Figures 22A-C).
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Figure 22. Legend:
(A) The first sample was incubated in 40 mM TCEP for 2 days, then in Tris, pH 7.0, for
1 and 6 days; (B) in 40 mM TCEP for 2 days followed by Tris, pH 7.0 for 1 and (C) 6
days. (D) The second sample was in KOAc, pH 5.7, for 2 days then in 40 mM TCEP
for 5 and 29 days; (E) in KOAc, pH 5.7, for 2 days followed by 40 mM TCEP for 5
days, and (F) in 40 mM TCEP for 5 and 29 days. (G) The third sample incubated in 40
mM TCEP for 2 days followed by KOAc, pH 4.0, for 5 days, 30 mM EDTA for 5 days
and then in KOAc, pH 4.0 for 7 and 16 days; (H) in 40 mM TCEP for 2 days, KOAc,
pH 4.0 for 5 days and 30 mM EDTA for 5 days; (I) in KOAc, pH 4.0 for 5 days and 16
days.

The CD spectra of reduced A4V protein, with 6 mM DTT, pH 5.5, at 4°C, again
showed an increased negative ellipticity between 250-220 nm (refer to Figures 23A-F).
Similar observations can be made in this section to those described with the prior TCEP
section. These results are in line with previous work done with SOD1 in solution (Tiwari
and Hayward, 2003; Fujiwara et al., 2005). Furthermore, the same CD regional change
mentioned above was also observed when A4V protein was incubated under other
destabilizing conditions such as pH 4.0 or addition of EDTA. This common change in
the CD spectra could be related to the A4V mutation, which decreases the global stability
of the protein (Hough et al., 2004). The A4V protein was shown to be more susceptible
to disulfide reduction than WT SOD1 protein in the present work.
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Figure 23. CD spectra of encapsulated A4V SOD1 following treatment with DTT. (A)
The first sample was incubated in 6mM DTT for 4 days, then in Tris, pH 7.0, for 2 and
16 days, (B) in Tris, pH 7.0, for 2 and (C) 16 days. (D) The second sample was
equilibrated in 6 mM DTT for 4 days followed by KOAc, pH 5.7, for 2, 16 and 50 days,
(E) in KOAc, pH 5.7, for 2, and (F) 16 and 50 days. (G) The third sample was in 6 mM
DTT for 4 days followed by KOAc, pH 4.0, for 2 and 16 days, (H) in KOAc, pH 4.0 for
2, and (I) for 16 days.

3.5

Fourth Aggregation Condition: TFE and Methanol
The denaturant effects of alcohols such as 2,2,2-trifluoroethanol (TFE) on protein

structure originate from the alcohol's low polarity, which is believed to interfere with the
hydrophobic forces stabilizing protein structure through the alcohols direct interactions
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with water (Voet and Voet, 2004). Furthermore, TFE has been shown to induce a helical
conformation in an all p-barrel protein (Srisailam et al., 2003). Also, methanol can cause
the formation of helical structure or p-like structure (caused by aggregation of the helical
intermediate form) depending on the specific protein or polypeptide (Wang et al., 1992).
Therefore encapsulated WT and A4V proteins were tested with various concentrations of
TFE and methanol to investigate the effect of these denaturants on the secondary
structure of SOD 1. All samples were encapsulated in sol-gel glasses made with KOAc,
pH 5.7. A4V samples that were previously exposed to different conditions were replaced
with various concentrations of TFE and methanol.
Three different WT glass samples were used. The first one was incubated in 15%
TFE at 4°C for four consecutive days. A CD reading was obtained for each incubation
day (Figures 24A-C). A change in the CD signal in the region around 208 nm was
detected indicating an increase in the helical content of the structure (Sreerama and
Woody, 2004). The next two samples were used to compare the effects of TFE and
methanol on WT secondary structure. The two samples started with identical initial
conditions, i.e., physiological pH and then 15% TFE at 4°C. When TFE concentration
and temperature were increased to 80% at 37°C, the secondary structure in the first
sample unfolded within one day (Figures 24D-F). Interestingly, when methanol was
added instead of TFE to the second sample, the secondary structure was largely restored
to its native conformation (Figures 24G-I). This recovery of the native conformation has
not been observed before.
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Figure 24. CD spectra in the far-UV of encapsulated WT SOD1 due to the effect of
TFE and methanol. (A) The first sample was placed at 4°C in 15% TFE for 1, 2, and 4
days, (B) for 1, 2, and (C) 4 days. (D) The second sample was in Tris, pH 7.0, for 1 day
followed by 15% TFE at 4°C for 5 days then in 80% TFE for 1 day at 37°C, (E) in
15% TFE at 4°C for 5 days, and (F) in 80% TFE for 1 day at 37°C. (G) The third
sample equilibrated in Tris, pH 7.0 at 4°C for 1 day, 15% TFE at 4°C for 5 days then in
80% MeOH for 1 day at 37°C, (H) in 15% TFE at 4°C for 5 days, and (I) in 80% MeOH
for 1 day at 37°C.

Two samples were used to study the effect of TFE and methanol on the secondary
structure of mutant A4V protein. The first sample was previously incubated in Tris, pH
7.0, at 4°C for two months. The near-native conformation was documented in Figures
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10D-E. Addition of TFE was performed to determine its effects on the A4V protein
exhibiting the stable near-native conformation since TFE has been shown to induce
aggregation in SOD1 (Stathopulos et al, 2003). Upon the addition of 15% and then
45% TFE at 37°C, an increase in negative ellipticity was detected in the CD regions
around 208 nm (similar to WT SOD1) and 225-235 nm. So, by increasing the TFE
concentration, A4V protein began to unfold (Figures 25A-C). The second experiment
used an A4V protein sample incubated in Tris, pH 7.0 for one month at 4°C. The CD
spectrum showed the loss of the prominent band in the region 228-230 nm, which is a
common feature observed in A4V protein under various aggregation conditions, i.e., low
pH with KOAc pH 5.7 and 4.0, (sections 3.2.2 and 3.2.3), EDTA (section 3.3), and
TCEP/DTT (section 3.4). When TFE was added at 4 and 37°C, no change in the
secondary structure was observed (Figures 25D-E). When low concentration of methanol
(15%) was added, the CD signal intensity decreased indicating leaching of some of the
encapsulated protein out of the sol-gel matrix (Figure 25F). The third experiment used a
reduced A4V protein sample. When various concentrations of TFE were added at 4 and
37°C, similar results were obtained as with the two previous experiments (Figures 25GH). When 80% methanol was added at 37°C, the A4V protein adopted a new
conformation with a distinct minimum in the CD region at around 215 nm as compared to
208 nm in the native structure (Figure 251). This minimum has been observed before
with the WT spectra but not with the A4V spectra. Further research needs to be done
using new samples of encapsulated A4V SOD1 to better understand the effects of TFE
and methanol.
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Figure 25. CD spectra in the far-UV of encapsulated A4V SOD1 as a function of TFE
and methanol. (A) The first sample was incubated at 4°C in Tris, pH 7.0, for 2 days,
then for 2 months followed by 15% TFE for lday, and for 2 hours at 37°C, then in
45% TFE for 1 day at 37°C, (B) in 15% TFE for 2 hours at 37°C, and (C) 45% TFE for
1 day at 37°C. (D) The second sample was equilibrated in Tris, pH 7.0, for lmonth at
4°C followed by 15% TFE at 4°C for 1 day at 4°C and for 2 hours at 37°C, then in 15%
TFE for 1 day at 37°C, (E) in Tris, pH 7.0, for 1 month, in 15% TFE for 1 day at 4°C
and 2 hours at 37°C (F) in 15% MeOH for 1 day at 37°C. (G) The third sample was
placed in 6 mM DTT for 2 days, in KOAc, pH 5.7 for 50 days, in 15% TFE for 1 day, in
25% for 1 day at 4°C, then in 15% TFE at 37°C followed by 45% TFE for 1 day and
then in 80% MeOH for 1 day at 37°C, (H) in KOAc, pH 5.7 for 50 days, then in 15%
TFE for 1 day at 4°C, then in 80% MeOH for 1 day at 37°C and (I) in 80% MeOH for 1
day at 37°C.
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3.6
3.6.1

Other Test Conditions
Effects of Salts on the Secondary Structure of hSODl
Some salts are known to have stabilizing effects on protein structure while others

have the opposite or no such effect (Jain and Ahluwalia, 1996). In this work, N(CH3)4C1
(TMAC1) was used to study its effects on the encapsulated hSODl proteins. This salt
was selected since it has been shown to have stabilizing effects on encapsulated proteins
that were denatured either due to the encapsulation process or through intentional
chemical denaturing (Eggers and Valentine, 2001b). In addition this salt exhibited
minimum interference with the CD spectrum in the far-UV region, which makes it a
perfect candidate for this study.
Two encapsulated WT samples and one A4V sample were incubated in 1.0 M
N(CH3)4C1, pH 7.0 and stored at 4°C. The first WT sample was encapsulated in a
standard sol-gel made with KOAc buffer at pH 5.7 (Figures 26A-C), and the second
sample was encapsulated in a sol-gel made with Tris buffer, pH 7.0 (Figures 26D-F').
Both samples were monitored for 54 days. A4V protein was encapsulated in a standard
sol-gel made with KOAc buffer, pH 5.7 (Figures 26G-H), and the sample was monitored
for 2 days. The spectra shown in Figures 26A-H indicate that N(CH3)4C1 had a
destabilizing effect on the secondary structure of the encapsulated protein. This was
surprising given that previous studies have shown opposite effects. The possible causes
for this apparent conflict are discussed in detail in Chapter 4.
The final conformations of the encapsulated proteins are compared in Figure 27
after normalization. The loss of the CD signal in the case of WT protein encapsulated
with sol-gel made with Tris buffer at pH 7.0, as shown in Figures 26D-F', is suspected to
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be mainly due to the pore size being larger as compared with the pore size of the sol-gel
made with pH 5.7 buffer. This is consistent with other CD measurements observed in
this study as will be discussed in section 3.6.2. The minor normalization for the A4V
signal was necessary due to the length of the incubation period (2 vs. 54 days) rather than
the pore size. This, unfortunately, was needed since the sample broke after the second
measurement. Interestingly, the CD spectra of the encapsulated A4V and WT proteins
were almost identical in this case, whereas in most other test conditions different effects
were observed on the encapsulated A4V and WT proteins.
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Figure 26. CD spectra in the far-UV of encapsulated WT and A4V SOD1 protein
equilibrated in 1M N(CH3)4C1. See legend on the following page.
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1

Figure 26. Legend:
(A) The first WT sample was encapsulated in standard sol-gel made with KOAc buffer,
pH 5.7 and monitored for 1, 2, 3, 7, 9, 11 and 54 days, (B) 7 and 11 days and (C) 54
days. (D) The second WT sample was encapsulated in standard sol-gel made with Tris
buffer, pH 7.0 and monitored for 1, 2, 3, 7, 9, 11 and 54 days, (E) 7 and 11 days and (F)
54 days. (D', E', and F') are normalized for D, E and F respectively. (G) A4V sample
encapsulated in standard sol-gel made with KOAc buffer, pH 5.7 and monitored for 1, 2
and, (H) 2 days.

-8 4

1

200

210

1

1

1

220
230
Wavelength (nm)

1

240

250

Figure 27. Comparison of final conformations of encapsulated WT and A4V SOD1
incubated in 1.0 M N(CH3)4C1. A4V sample encapsulated in standard sol-gel made with
KOAc buffer, pH 5.7 was incubated for 2 days is compared to WT samples incubated
for 54 days (in sol-gel made with KOAc buffer, pH 5.7 and with Tris buffer, pH 7.0
normalized signal). Both WT and A4V references are shown.

3.6.2

Effect of pH 8.0 on the Encapsulated hSODl
Protein leaching out of the sol-gel pores presented a major problem in this

research. It was noted that as the pH increased from 5.7 to 7.0, so did the leaching from
the sol-gel. This loss could be attributed to the electrostatic interaction between the solgel matrix and the protein. Human SOD1 is predicted to have an isoelectric point (pi)
around 5.8, hence at pH 7.0 and above the protein carries a net negative charge (Shaw
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and Valentine, 2006). In addition, the silica pi is about 2.1, so at higher pH the silica
walls become negatively charged (Nguyen et al., 2002) and that would create an
electrostatic force that would repel the protein from the pores. To confirm this
observation, two encapsulated WT samples and one encapsulated A4V sample were
incubated in Tris buffer, pH 8.0 at 4°C for 54 days and 12 days, respectively. As will be
discussed further in chapter 4, the net charge of the protein in pH 8.0 buffer is expected to
be significantly more negative as compared with that in pH 7.0 (-7.3 and -3.2,
respectively). The low temperature (i.e., 4°C) slowed down the leaching process and
allowed careful monitoring of the loss rate. The two WT samples were prepared using
the standard sol-gel protocol. One was made with Tris buffer, pH 7.0 (Figures 28A-A')
and the other was made with KOAc buffer, pH 5.7 (Figures 28B-B'). Similarly, the A4V
sample was prepared using the latter method (Figures 28C-C).
First, the general trend is established by comparing the spectra shown in Figure
11, Figures 10A-C, and Figures 28A-B corresponding to WT samples incubated in
different buffers with pH 5.7, pH 7.0 and pH 8.0, respectively. This confirmed that as the
pH increased, the protein signal decreased. Similarly, for the encapsulated A4V sample,
by comparing the spectra shown in Figure 28C and Figures 14A-B, an analogous trend is
observed. In order to determine the rate of protein leaching due to the above
observations, the normalization factors used to achieve the same ellipticity value near the
minimum are used to calculate the loss percentage under various conditions. As shown
in Figure 29, the rate of protein leaching correlates with the buffer pH as well as the solgel preparation method. Under identical incubation conditions, the extent of leaching of
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S0D1 encapsulated in standard sol-gel glasses made with KOAc buffer at pH 5.7 is
found to be always lower than that encapsulated in sol-gel glasses made with Tris buffer
at pH 7.0. This suggests that the pore size is smaller for the sol-gel prepared with pH 5.7
as compared with pH 7.0. In addition, the pH of the buffer used for incubation appears to
have a more significant effect on SOD1 leaching rate as shown in Figure 29.
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Figure 28. CD spectra in the far-UV of encapsulated WT and A4V SOD1 incubated in
Tris pH 8.0 at 4°C. (A) WT sample was encapsulated in standard sol-gel made with Tris
buffer, pH 7.0 and monitored for 1, 2, 3, 7, 9, and 54 days. (B) WT sample was
encapsulated in standard sol-gel made with KOAc buffer, pH 5.7 and monitored for 1, 2,
3, 7, 9, and 54 days. (C) A4V sample encapsulated in standard sol-gel made with KOAc
buffer, pH 5.7 and monitored for 1 and 12 days. (A', B', and C ) are normalized for A,
B and C respectively.
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Figure 29. Effects of buffer pH and sol-gel preparation methods on encapsulated
protein-leaching rate.

3.6.3

Bovine SOD1 (bSODl) Tests under Various Conditions
Parallel tests were conducted using bSODl, rather than human WT or A4V, in

order to establish test guidelines and to avoid the potential waste of the limited amount of
WT and A4V proteins available for this study. These tests were primarily focused on
addressing the following: 1) Effects of the sol-gel encapsulation on the protein's
secondary structure as compared with that in solution when incubated in pH 7.0 buffer.
2) Stability of the encapsulated protein under various test conditions and determination of
how long the protein structure remains stable in the encapsulated environment. 3) Effects
of the different types of sol-gel glasses used in this study (i.e., 100% TMOS and 10%
propyl-modified glass). 4) Changes in the secondary structure of the protein under the
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influence of various pH, salts, and other aggregation conditions such as low pH, EDTA,
and heat.
First, the CD spectrum of native bSODl in solution (10 raM Tris, pH 7.0) was
obtained and compared with the literature (Foti et al., 1997). Both signals were similar,
and the spectrum obtained was used as the bSODl reference for all the following tests
(Figure 30). Next, two different encapsulation processes were used to determine the
impact on the secondary structure. The first encapsulation process was based on the
standard sol-gel method described in (Eggers and Valentine, 2001a), and the buffer used
was Tris, pH 7.0. The second process included a 10% propyl-modified sol-gel. As
shown in Figure 30, the encapsulation processes produced minor effects on the secondary
structure of bSODl protein.
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Figure 30. Effects of the encapsulation process on bSODl. The first sample was
encapsulated with a standard sol-gel protocol, and the other sample with a 10% propylmodified sol-gel protocol. Both samples were incubated with Tris buffer, pH 7.0, at
4°C. bSODl in solution was used as the reference.

Protein leaching out of the sol-gel pores, causing loss of the CD signal, was a
major problem for this protein. To circumvent this issue, sol-gel samples were used
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immediately after the two weeks of maturation, and samples were kept at 4°C except
during CD measurements, which were conducted at 25°C unless stated otherwise. As
observed in Figure 31, most of the samples had a sufficient amount of protein to produce
a good CD signal even after 12 days of incubation, although the samples incubated in 10
raM Tris buffer at pH 8.0 and N(CH3)4C1 were weaker. The two different encapsulation
processes also produced similar spectra (Figures 31A-F' and Figures 31I-F) except for
N(CH3)4C1. The effects of N(CH3)4C1, as described previously, are discussed further in
Chapter 4. Finally, the denaturation effects resulting from heat treatment, as shown in
Figure 31H, are not only irreversible, but in fact appear to continue further when the
sample is stored at 4°C after treatment.
The effects of the different encapsulation processes on the secondary structure of
bSODl are compared under various incubation conditions (Figures 32A-C). Again no
major difference is observed aside from the N(CH3)4C1 case, which is the same data
shown in Figures 31F-F'.

80

A

Buffer: Tris pH 7.0

B

c

Buffer: KOAc pH 5.7

Buffer KOAc pH 4.0

D

Buffer: EDTA

Buffer:
Varies
Storage Temp.:
4"C

reference
1 day
4 days
6 days
12 days

Sol-gel
10% propyl:
Made with
KOAc, pH 5.7

(

/l\
H

200

210

E

•D

.3.

E

_4,

|

-5.

o

-6'

240

250 200

240

250 200

F Buffer: TMACI

1220
230
Wavelength (nm)

Wavelength (nm)

Buffer: Tris pH 8.0

H

/

x -7,
ST
" -8'
-9'
i

i

210

220

Jf

1—»—i
230 •

!00

210

220
230
Wavelength (nm)

JT

^
\^/i

M
WSf
W&
\ . y

reference
— - 1 day
—•—4 days
—•—6 days
_ _ 12 days

'•
.
.
•

i

i

1

H Buffer: Tris pH 7.0 + heat

reference

— @25X

— 8 37X
— @ 45X
— @ 55X
— @ 65X

— 9 75X
— @ 85X
_ — . — , ~ « j y p

i

240

250 200

210

•

^

jV,
ff
/
f
—i
210

Wavelength (nm)

reference
_ ^ 1 5 min, @ 95X
- » - 4 days, @ 4 X
- * - 6 days, @ 4 X
-^•12days, @ 4 X
1

i

220
Wavelength (nm)

% normalized
A E'

_-.

~ -1'
O -2'
E
degcm

"D - 3 '

o -6'

-9'
200

Buffer:
Varies,
for 1 day

210

i

i

220

230

i
210

L ]

g
reference
M _~-pH7.0
_*_pH8.0
j§

\

\~y

220
230
Wavelength (nm)

240

__

R

Storage Temp.:
4°C
Standard sol-gel:
Made with
Tris, pH 7.0

reference
—
1day
—•—4 days
—«— 6 days
— _ 12 days

reference
- • - 1 day
—<— 4 days

s "7*

f

,
i—— i

reference
-^_pH7.0
— pH8.0
—pH5.7
-~~EDTA
— - TMACI

normalized
•*•

_*-pH5.7
~—EDTA
—TMACI
1

220
230
Wavelength (nm)

240

y^

~~~~'

reference
—•—1 day
—•—4 days
- * - 6 days
_*_12days

V

2S

G Buffer: Tris pH 7.0 + heat

ir

Sfa0**&r

-1'
•5 -2<
E

220
230
Wavelength (nm)

reference
- * - 1 day
— * - 4 days
—^-6 days
_^_12days

i
200

210

220

230

240

250

Figure 31. CD spectra in the far-UV of encapsulated bSODl incubated in various
conditions. See legend on the following page.
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Figure 31. Legend:
Samples in spectra from (A-H) were encapsulated in a 10% propyl-modified glass, and
incubated for 12 day at 4°C with the exception of the sample in (G-H). (A). Samples
were incubated in Tris buffer, pH 7.0, (B). in KOAc buffer, pH 5.7, (C). in KOAc
buffer, pH 4.0, (D). in EDTA, (E). in Tris buffer, pH 8.0, (E'). Normalization of (E),
(F). inN(CH3)4Cl and (F'). Normalization of (F). (G). bSODl sample was incubated in
Tris, pH 7.0, for 1 day and then heated from 25-95°C, afterward stored at 4°C, and
readings were taken after, (H). 4, 6 and 12 days. (I). CD readings were obtained of
samples encapsulated in the standard sol-gel and incubated for 1 day at 4°C in Tris, pH
7.0 and 8.0, KOAc, pH 5.7 in EDTA and N(CH3)4C1. bSODl in solution was used as the
reference.
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Figure 32. Comparison of CD spectra in the far-UV of encapsulated bSODl using the
standard sol-gel and the 10% propyl-modified glass in various buffers. All samples (AC ) were incubated for 1 day at 4°C. (A). Samples were incubated in Tris, pH 8.0, (B)
in KOAc, pH 5.7, (C) in N(CH3)4C1, and (C) Normalization of (C). bSODl in solution
was used as the reference.
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3.6.4

Other Test Conditions: Xerogel
Encapsulation of WT SOD1 in xerogel was investigated under five conditions.

While samples incubated in Tris buffer, pH 7.0, KOAc, pH 5.7 and EDTA unfolded, the
sample incubated in N(CH3)4C1 did not (Figures 33A-A'). Given that in the xerogel
protocol more shrinkage and water loss occurred as compared with the standard wet-aged
sol-gel process, the resulting average pore sizes are assumed to be much smaller (Pierre,
2004). This could contribute significantly to the loss of the secondary structure of the
protein due to the presence of small amount of entrapped water surrounding the protein in
the pores as well as the silica matrix interaction (Eggers and Valentine, 2001a, 2001b).
The beneficial effects of N(CH3)4C1 in this case are discussed in Chapter 4.
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Figure 33. CD spectra in the far-UV of encapsulated hSODl WT in xerogel. (A).
Samples were incubated in Tris buffer, pH 7.0, KOAc buffer, pH 5.7, EDTA and
TMAC1 for 1 day at 4°C. (A') normalization of (A). The reference is a sample of WT
encapsulated in standard sol-gel incubated in Tris buffer, pH 7.0, at 4°C.
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CHAPTER 4
4.0 Discussion and Conclusions
This study demonstrates that the encapsulation of CuZnSOD proteins (human
WT, mutant A4V, and bovine) in sol-gel matrices is a viable approach to isolate
intermediates that would normally lead to aggregation in dilute solutions. The findings in
this study are pertinent from two perspectives. First, since protein aggregation in solution
is inevitable under various denaturing conditions, establishing the effects of such
conditions on the structure of these proteins is difficult, if not impossible, in some cases.
This is especially true for the mutant SOD1 A4V protein since it has been shown to
aggregate spontaneously in vitro under conditions at which the WT protein remains stable
(Ray et al., 2004). Second, the effects on protein structure due to molecular crowding
and confinement in the cellular environment are mimicked by protein encapsulation in
the sol-gel (Eggers and Valentine, 2001a). Given that most of the previous studies on
SOD1 have been conducted in dilute solutions, understanding the influence of the highly
crowded cellular environment on protein stability and dynamics is of great interest
(Zimmerman and Minton, 1993; van den Berg et al., 1999; Ellis, 2001; Zhou and Dill,
2001). The secondary structure of the entrapped proteins was investigated using circular
dichroism in the far-UV region (200-250 ran). Near-UV measurements and tertiary
structure impact were out of scope in this study given the limited amount of protein
available (i.e., protein concentration in the samples should be at least five times that used
in this study). Various sol-gel processes were investigated as described below, and two
types of wet-aged sol-gels were found to be most suited for hSODl entrapment with low
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protein concentration. Finally, the influences of several denaturing conditions on the
secondary structure of entrapped proteins are explored further in this chapter, and the
most important finding of a "stabilized partially unfolded state" will be discussed at the
end of this chapter.

4.1

Impact of the Various Sol-gel Methods on the Structure of Encapsulated
Proteins
In this section, general findings related to the effects of sol-gel encapsulation,

pore sizes, entrapped water and pH are discussed.

4.1.1

Sol-gel Methods: Summary and Findings
Four sol-gel preparation methods were investigated in order to determine the

impact of encapsulation on protein structure as well as to find a way to limit the protein
leaching problem that plagued the initial tests. The silica sol preparation methods used in
this study were based on the standard protocol described in the literature (Ellerby et al.,
1992; Eggers and Valentine, 2001a). These methods are enumerated in the following
with the associated impact on protein structure and leaching.
1. Standard wet-aged gels: The silica sols were prepared using two different buffers,
namely, Tris, pH 7.0, and KOAc, pH 5.7. For brevity, the resulting glasses
70

containing the entrapped proteins are referred to, hereinafter, as sol-gel

and sol-

gel5 7, respectively. WT SOD1 was encapsulated using both gel types, whereas the
mutant A4V protein was encapsulated only in sol-gel5 7 due to the limited amount of
70

protein available. Bovine SOD1 was encapsulated using sol-gel
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and other sol-gel

types as described below. In the absence of denaturant, protein encapsulation in
these glasses was found to induce a very minor change to the protein's structure as
compared with that in solution at pH 7.0 at 25°C (Figure 8A). However, protein
leaching was higher with sol-gel7 ° as compared with sol-gel5'7, particularly when the
glasses were incubated in buffers with a pH higher than the protein's pi ~ 5.8 (i.e.,
when the encapsulated protein is negatively charged). In the presence of
denaturants, the encapsulated proteins in these different glasses exhibited slightly
dissimilar structural changes under identical incubation conditions with few
exceptions. The most probable cause for this, as discussed in section 3.6.2, is that
the average pore size of sol-gel7 ° is larger than sol-gel5'7. This would explain both
the higher protein leaching observed with sol-gel70 as well as the slight difference in
the structural changes of the encapsulated proteins under various incubation
conditions.
2. Xerogel: This method was considered for two reasons: 1) it offered a potential
means to eliminate the protein leaching problem; 2) xerogels are less brittle than
wet-aged sol-gels that broke more often than desired. Unfortunately, the resulting
CD signal intensity was extremely weak, and the protein denatured significantly.
While in a previous study, bovine SOD1 was successfully encapsulated in a xerogel
and remained active (Ellerby et al., 1992), the concentration used in that study was
about forty times that of the concentration used in this study (0.65 mM vs. 0.0156
mM). Thus, the higher concentration was not an option for this study based on the
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required amount of protein and the fact that the absorbance would be too high for
CD measurements in the far-UV.
3. Propyl modified glass: The addition of the propyl groups to the silica matrix was of
interest based on the results reported in previous studies (Pierre, 2004; Rocha and
Eggers, 2007); however, the encapsulation of SOD 1, using this method, resulted in
leaching of the protein. Consequently, the CD signal intensity was very weak in
comparison with the 100% TMOS (standard) glass even when an identical protein
concentration was used in the preparation. Therefore, with the 10% propyl-modified
glass, the protein concentration needed in the sample should be more than doubled
that of the standard glass to compensate for the leaching problem. In addition, the
physical nature of the 10% propyl-modified glass samples was found to be
extremely brittle. This resulted in a large percentage of samples breaking due to
handling (i.e., removal from the quartz cuvette for storage and the reverse process).
As a result, aside from the bSODl encapsulation tests shown in section 3.6.3, this
method was not preferred for hSODl encapsulation.
Thus, most of the experiments in this study used the standard wet-aged sol-gel for
encapsulating both WT and A4V SOD1. The protein leaching issue was partly addressed
by using sol-gel5' for most of the tests, as well as storing the samples at 4°C, which was
found to lower the leaching rate further. Lastly, in cases where protein leaching could
not be avoided (i.e., when the pH buffer was higher than the protein's pi 5.8), CD data
normalization was used to compensate for the resulting loss of protein concentration (i.e.,
approximate the signals at the same concentration).
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4.1.2

Impact of Sol-gel Pore Size on Encapsulated Protein Structure
Since the average pore size of the different glasses appears to have a definite

impact on the protein leaching at elevated pH (section 3.6.2), the associated impact on
protein folding was investigated. Comparison of the CD spectra of encapsulated WT
SOD1 in the different glasses under various incubation conditions reveals that there is a
definite impact in most cases except one, namely, with N(CH3)4-C1. As shown in Figures
11, 15, and 17, corresponding to incubation in KOAc buffer at pH 5.7, pH 4.0, and in
EDTA, respectively, the intermediate and final structural changes were different. In the
case of N(CH3)4C1, it is suspected that the additional hydrophobic interactions
predominate over the electrostatic forces (Jain and Ahluwalia, 1996) resulting in identical
protein conformation. This will be discussed further in section 4.2. In the case of the
xerogel, it was expected that the protein conformational change would be different than
the wet sol-gel due to the smaller pore size. However, the data gathered in this case is
considered unreliable due to the limited protein concentration used as discussed
previously, and the resulting signal to noise ratio. On the other hand, the xerogel data
could be viewed as a very rough estimate. With that in mind, the data show that there is a
definite difference in protein structure when incubated in N(CH3)4C1 as compared with
other buffers (section 3.6.4, Figure 33) regardless of the sol-gel method used for
encapsulation.
4.1.3

Effect of Water Confinement in the Silica Pores
While there is certainly no shortage of theories and hypotheses regarding the

critical role that water plays on protein folding, many of the physical properties of water
itself remain elusive (Stanley et al., 2007). Nevertheless, recent experiments have
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revealed an intriguing water property when confined in silica nanotubes made with
MCM-41 with pore diameter of 15 ± 1 A (Liu et al, 2007, Stanley et al, 2007). Such
confinement changed the water behavior significantly such that water remained in the
liquid state when supercooled down to 160 K (-113°C). In other studies, different aspects
of confinement on water structure and dynamics are discussed. Takamuku and
colleagues (1997) showed various water structure and dynamic properties depending on
water confinement in porous silica of two different pore sizes (30 and 100 A).
Furthermore, the vibrational energy of confined water molecules in porous silica, with
pore size of 90 A at ambient temperature, is proven to be lower than that of
bulk/unconfined water (Hall et al., 1981).
The observations above suggests that the loosely defined "bulk water" should not
be assumed to possess the same properties as the "confined bulk water" within the silica
pores, and that the properties of the confined water is also critically dependent on the
level of confinement (i.e., water properties could be slightly different in pore sizes of 15,
30, and 100 A). The relevance of these observations to this study is that the
conformational changes noted in the previous section relating to pore sizes may not only
be due to the obvious variable restriction on the rotational movement of the protein, but
that the change in water properties in these pores is an important factor. The average
pore size for the gel 70 is assumed to be around 100 A (Eggers and Valentine, 2001a), but
the reduction of the average pore size with sol-gel

is unknown. However, considering

the dimensions of the encapsulated SOD1, and considering that the encaging silica matrix
around the protein does not form a perfect sphere, the amount of water entrapped
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between the surface of the protein and the silica structure could be different even with a
small change in the average pore size.
In addition to the water structure factor, there are other important considerations
resulting from encapsulation such as the electrostatic interaction between the protein and
the silica matrix. In particular, under most test conditions the active site of SOD 1 is
positively charged whereas the silica walls are negatively charged (pi around 2.5). This
may not only be a factor after the encapsulation process is complete, but may play a role
in the formation of the silica matrix around the protein. For instance, with the sol-gel70
protocol, while the net charge of the protein is negative, the active site is still positive
while other parts of the protein's surface are negatively charged. Hence the formation of
the silica matrix around the protein may favor interaction with certain parts of the
protein's surface but not others. This is illustrated in Figure 34 by calculating the
electrostatic potential around the WT SOD1 at pH 7.0 using DeepView/Swiss-pdb
Viewer V3.7. The protein's data used for the model was obtained from the Protein Data
Bank (PDB, ID 2C9V).
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Figure 34. Electrostatic field around the SODldimer at pH 7.0. Calculations were done
using DeepView/Swiss-pdb Viewer V3.7. Protein data was obtained from PDB, ID
2C9V.

4.1.4

The Effect of pH 8.0 on Leaching
As discussed in section 3.6.2 in Figure 29, there was a significant increase in

protein leaching when incubated in pH 8.0 as compared with pH 7.0 buffers. This was
surprising since the encapsulated protein did not show a major change in the secondary
structure, which could have easily been explained by the change in the net charge of the
protein (i.e., more residues become solvent exposed). Furthermore, this observation was
consistent with hSODl (WT and A4V) and bSODl using different sol-gel protocols.
This increase in the net negative charge is obviously due to more residues on the protein
becoming deprotonated with pH 8.0, but which residues was unclear. To address this, the
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following two basic questions are considered: which residues are the potential suspects,
and are these residues exposed, or partially exposed, to solvent in the native fold?
First, all of the 153 amino acids per WT SOD1 subunit are listed, and the
frequency of each is plotted as shown in Figure 35. Among these, the polar-charged
basic or acidic residues are highlighted. The pK.Rof the side chains of both lysine and
arginine are above 10, and are therefore always positively charged at pH 7.0 and 8.0.
Aspartate and glutamate have PKR around 4, thus will be negatively charged in the above
pH range. This leaves the amino acid residues histidine and cysteine as the major
suspects with pK.R of 6.04 and 8.37, respectively. Using the Henderson-Hasselbach
equation, the fraction of the His and Cys side chains carrying a positive charge vs. pH is
plotted as shown in Figure 36. From the figure, 90% of His side chains are deprotonated
at pH 7.0, and an addition 9% will be deprotonated at pH 8.0. Similarly, for Cys an
additional 26% will be deprotonated at pH 8.0. However, this assumes that the His and
Cys residues are solvent exposed and there are no interactions with other residues. As a
result, the next step is to look at where the His and Cys residues are located on the protein
and their states.
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Figure 35. Plot of all the amino acids found in a WT SOD1 subunit. Polar acidic and
basic amino acid residues are negatively and positively charged, respectively. The blue
color indicates the positively charged amino acid residues, and the red color the
negatively charged amino acid residues at pH 7.0. The percentage of each amino acid
residue out of the 153-total is shown at the bottom.

Figure 36. Fraction of histidine and cysteine side chains carrying a positive charge at
different pH values.
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Out of the eight His amino acids present per SOD1 subunit, six (His , His ,
His .His'SHis^andHis"") are involved in the copper and zinc metal binding site, and
two are not (Goto et al., 2000). The remaining two are: His 43 , which is buried in the |3strand 4 and thus inaccessible, and His n o is solvent exposed as shown in Figure 37
(PDB: 2C9V and MBT Protein Workshop were used to generate the views). In addition,
out of the four Cys residues, two form the disulfide bond (Cys57 and Cys146), Cys6 is
buried, while Cys111 is solvent exposed. As a result, in the fully metallated dimer, two
His n o and two Cys111 residues could be deprotonated further at pH 8.0. However, it
should be noted that this estimate does not take into account the pK shifts related to the
folded protein. The protein's net charge under different pH values was estimated by
using a public tool (http://www.scripps.edu/cgi-bin/cdputnam/protcalc3'), as shown in
Appendix-A. Based on the output, the protein's net charges are estimated to be -4.2 and 7.3 at pH 7.0 and 8.0, respectively. This difference may be significant enough to justify
the major increase in protein leaching observed at pH 8.0 due to increased charge
repulsion.
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m\
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Figure 37. Structural views of holo-WT SOD1 subunit showing the positions of the
solvent exposed His110 and Cys111. (Figure from PDB, ID 2C9V, 180° rotation)

4.2

N(CH3)4C1 Effect on Encapsulated SOD1
The effect of N(CH3)4C1 on the secondary structure of entrapped SOD1 was found

to be denaturing to the native conformation with one exception, namely, the xerogel
encapsulation. This was surprising given that this salt has been shown in previous studies
to produce a stabilizing influence on the structure of various proteins in aqueous solutions
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(lysozyme) as well as proteins entrapped in sol-gel glass (apomyoglobin and serum
albumin) (Jain and Ahluwalia, 1996; Eggers and Valentine, 2001a, 2001b). Since this
apparent contradiction maybe due to several factors, a number of tests are compared
below to determine the possible causes. Another intriguing observation was that the
denatured structure for both the entrapped WT and A4V SOD1 appeared to be almost
identical, which was a rare exception in this study. Furthermore, the conformation
appeared to be a "stabilized" partial unfolding that was noticed with the WT SOD1 using
different denaturing conditions. This will be discussed further at the end of this section,
but first the apparent inconsistency with the studies listed above needs to be addressed.
In this study, six different sol-gel samples were subjected to N(CH3)4C1 treatment
as summarized in Table 2 below. The denaturation influence of N(CH3)4C1 was
confirmed with all but the xerogel case, where the effect appeared to be stabilizing
(Figure 33). Also it is important to note that the xerogel encapsulation process denatured
the protein significantly, and in that case the addition of N(CH3)4C1 countered the
denaturing influence of the silica matrix. Thus, this part is consistent with previous
studies (Eggers and Valentine, 2001a, 2001b). However, with other sol-gel methods the
encapsulation process did not denature the protein's native fold and the effect of
N(CH3)4C1 in this case was denaturing. This destabilizing effect of N(CH3)4C1 was also
observed in solution by Koga and co-workers (2006). These results suggest that the
additional hydrophobic or electrostatic interactions introduced by the addition of
N(CH3)4C1 are not necessarily always stabilizing (Jain and Ahluwalia, 1996).
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Table 2. Summary of N(CH3)4C1 effect on SOD1 using different sol-gel preparation
methods.
Sol-gel preparation protocols

Effect on
entrapped
WThSOD1

Effect on
entrapped
A4VhSOD1

Effect on
entrapped
WTbSOD1

sol-gel prepared
with KOAc pH
5.7
(gel 5 7 )
Destabilizing
the initial native
fold, but new
conformation is
stable.
(Figure 26C)
Destabilizing
the initial native
fold, but new
conformation is
stable
(Figure 26H)

not tested

sol-gel prepared
with KOAc pH 7.0
(gel 7 0 )

10% Propyl
modified glass

Xerogel

Destabilizing the
initial native fold,
but new
conformation is
stable
(Figures 26F-F)

not tested

Stabilizing
(Figure 33)

not tested

not tested

not tested

Destabilizing the
initial native fold,
but new
conformation is
stable
(Figures 32C-C)

Destabilizing
the initial native
fold, but new
conformation is
stable
(Figures 32CC)

not tested

In addition to the above, the different results observed with this and previous
studies may involve other factors relating to the type of proteins used. For instance, by
comparing the secondary structure of SOD1 with the two proteins used in previous
studies, namely, apomyoglobin and serum albumin (Eggers and Valentine, 2001b), the
following differences are revealed: a) both apomyoglobin and serum albumin proteins are
mostly alpha helical (75% and 72% helical content, respectively); b) SOD1 proteins have
a very small alpha helical content (only 7% helical, 39% beta sheets, and 54% random
coil); and c) the percentage of hydrophobic residues on the surface of the proteins may be
another factor that is relevant in this case. Furthermore, by comparing different older
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studies (von Hippel and Wong, 1965; Jain and Ahluwalia, 1996) relating to the influence
of N(CH3)4C1 on different proteins in solutions reveals that the results are not consistently
stabilizing either. Based on Jain and Ahluwalia, (1996) the thermal denaturation stability
(Tm) of Lysozyme protein in aqueous solutions varies depending on N(CH3)4C1
concentration. At high concentration (5-6 M), N(CH3)4C1 demonstrates stabilizing
influence on the protein's thermal stability, but at concentrations below 4 M N(CH3)4C1
the opposite is true i.e., N(CH3)4C1 is indeed destabilizing. On the other hand, it was
shown that the thermal stability of ribonuclease protein improves with N(CH3)4C1
concentration of 0.5- 3 M (von Hippel and Wong, 1965).
In summary, the effects of N(CH3)4C1, stabilizing or otherwise, are dependent on
various factors including the protein type, N(CH3)4C1 concentration, initial folding state,
and the crowding environment.

4.3

The Effect of N(CH3)4C1, pH 4.0 and TCEP on the Secondary Structure of
Encapsulated SOD1
The effects of N(CH3)4C1 on the entrapped SOD1 (WT and A4V) were found to

be remarkably similar even when the encapsulation processes were different i.e., using
sol-gel70 and sol-gel5'7. As mentioned previously, it is suspected that the additional
hydrophobic interactions and/or the influence of N(CH3)4C1 on the bulk water
predominate over the pore size difference in this case. Intriguingly, the conformational
changes for both the entrapped WT and A4V proteins appeared to be in a "suspended"
partially unfolded state even after 54 days of incubation. In other words, the unfolding of
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the encapsulated proteins was somehow halted, and the resulting denatured state was
stable. Thus the key points that this section will focus on are what stabilized the protein
in this state, and is there a different path to this state.
First, the CD spectra of this "suspended" partially unfolded state (i.e., N(CH3)4C1
measurements) are compared with other test data, and several conditions shown in Figure
38A appeared to produce similar CD spectra after normalization. The first comparison
shows the CD spectrum of encapsulated WT-hSODl when incubated in pH 4.0 at 4°C for
54 days (Figure 15C), and the second is that of encapsulated A4V SOD1 under similar
conditions but after only 2 days (Figure 16A). While the encapsulated WT SOD1 was
stable after 54 days, A4V SOD1 under identical conditions continued to a complete and
irreversible unfolding (Figure 16C). Furthermore, the encapsulated WT SOD1 sample
described in section 3.2.2 (Figure 12G) appeared to refold to this "suspended" state even
after being exposed to various buffers over 110 days. Finally, similar conformational
changes were observed with EDTA (Figures 171 and 18C) implying metal loss.
The above mentioned confirmations, at least in the 225-235 nm region, appeared
also to be somewhat similar to the CD spectra of encapsulated WT-hSODl intermediate
on the way to complete unfolding after TCEP treatment at 37°C (Figure 20D) after
normalizing. Because this implied a potential reduction of the disulfide bond, the two
samples that were previously incubated in the N(CH3)4C1 and KOAc (pH 4.0) were
incubated afterwards in 40mM TCEP buffer for one day. The results demonstrated a
slight structural change in the 225-235 nm and 200-208 nm regions (Figure 38B). Thus
in order to determine if this minor difference was indeed due to a slight structural change
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and in order to rule out potential measurement errors, the effects of TCEP and DTT on
WT SOD1 in solutions were compared with the CD spectra of encapsulated proteins. The
effect of TCEP on WT SOD1 in solution was investigated as part of this study, but the
effect of DTT in solution was based on a previous study (Fujiwara et al., 2005) as shown
in Figure 38C. The results were consistent, confirming that both TCEP and DTT had a
slightly different impact on the protein's secondary structure as compared with the effects
of N(CH3)4C1 and KOAc at pH 4.0.
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Figure 38. CD spectra of "suspended" partial unfolding for WT and A4V SOD1 under
different conditions. (A). The first WT sample was incubated in TMAC1 for 54 days at
4°C, the second sample in pH 4.0 for 54 days at 4°C, and the third sample was
incubated in TCEP for 1 day at 37°C. The first A4V sample was incubated in TMAC1
for 2 days at 4°C, the second sample in pH 4.0 for 2 days at 4°C, and the third sample in
TCEP for 2 days at 4°C. (B). WT sample was incubated in TMAC1 for 54 days, then
washed and replaced with TCEP. Another WT sample was incubated in pH 4.0 for 54
days, then washed and replaced with TCEP. (C). The first WT incubated in TCEP after
TMAC1, the second WT sample was equilibrated in TCEP after incubation in pH 4.0,
the third WT sample in solution incubated in TCEP, and last WT sample incubated in
DTT in solution taken from Fujiwara et al., 2005.
From the above, it is clear that the disulfide bond was being impacted by
incubation in either N(CH3)4C1 or KOAc pH 4.0 buffers, given that the change in the
region between 225-235 nm was typically associated with the disulfides (Sreerama and
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Woody, 2004). Metal loss was another possibility given the similarity with the EDTA
CD spectra. However, this raises two more questions: 1) Why is there a difference in the
225-235 nm spectra in the TCEP test as compared with the N(CH3)4C1 and pH 4.0 tests?
2) Because the encapsulated WT proteins completely unfolded under the influence of
either TCEP or EDTA and similar complete unfolding was observed in solution, what
stabilized the unfolding process?
One hypothesis was the formation of a non-native intramolecular disulfide bond
involving Cys andCys

n

. This would not only stop the unfolding and stabilize the

intermediate as observed but would also produce a slight difference in the CD spectra in
the 225-235 nm region. In a recent study, Wang et al., (2006) suggested such a
possibility as quoted below:
Although we focus discussion on intermolecular disulfide bonds, it is important
to note that non-native intramolecular bonds could also occur, that is bonds
involving Cys residues other than the native bond between C57 and C146, and
that such bonds could stabilize non-native conformations. Hence, non-native
disulfide bonding could play a role in both misfolding of the monomer and
stabilization of multimers.
There was evidence of such scrambling of disulfide linkage involving Cys111 (nonnative) and Cys146 (native) that was noticed with apo-SODl in vitro after an extended
storage period at 4°C (Di Noto et al., 2005). In addition, other recent studies also
implicated Cys

n

in the formation of intermolecular disulfide cross-linking leading to

aggregation (Banci et al., 2007; Cozzolino et al., 2008). The creation of intermolecular
disulfide links with the sol-gel-entrapped proteins is very unlikely due to the silica
matrix. However, the structural changes that lead to the formation of intermolecular
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bonds in solution could also produce non-native intramolecular disulfide bonds in the
encapsulated environment. This hypothesis, of course, requires further validation,
perhaps by repeating the experiment and doing additional testing in the near UV in the
CD to obtain information regarding the tertiary structure and the disulfide bond. While
other explanations for the above "suspended", partially unfolded intermediate are
possible, the non-native disulfide bond hypothesis is the most plausible candidate.

4.4

Effects of TFE and Methanol on Encapsulated SOD1
Before discussing the effects of alcohols used in this research, it is important to

note that the A4V samples were previously incubated and tested in the various conditions
listed in section 3.5 Figure 25. Thus the results observed could reflect the additive effects
of multiple solution exchanges.
As observed in section 3.5, low TFE concentration increased the helical content in
the WT as well as A4V SOD1 secondary structure. When the TFE concentration and
temperature were increased to 80% and 37°C, the WT protein unfolded. On the other
hand, when 80% methanol at 37°C was added to the partially unfolded WT protein, a
recovery of the secondary structure was detected. Under the same conditions, the
partially unfolded, reduced A4V protein exhibited a new secondary structure with an
intense minimum at around 212 nm (as compared to 208 nm), and the absence of the
peak in the region of 225-235 nm. These data raise an interesting question: Why did the
SOD1 behave differently under the effects of these alcohols?
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One possible answer is based on the physiochemical properties of the alcohols
and their acidity compared to water. TFE with a pKa of 12.4 was more acidic than water
(pKa of 15.7). From infrared and NMR spectroscopies, it was found that the increased
acidity could decrease the fraction of water molecules with nonbonded lone pairs
(Symons, 1981). Therefore, the increased acidity of TFE made water "less hydrogenbond competent" (Kentsis and Sosnick, 1998). As a result, the occurrence of hydrogen
bonding between amides and carbonyl moieties on the SOD1 and TFE was probably
diminished, and that could lead to desolvation of the protein. On the other hand,
methanol with a pKa of 15.0 was less acidic than TFE, and at high concentration had the
opposite effect to TFE; it allowed WT protein to refold to the native conformation most
likely due to the strong intramolecular hydrogen bonds in the protein main chain.
Recently, it was observed that at high methanol concentration of 80%, as the hydrogen
bonds between the protein and the solvent became weaker, the intramolecular hydrogen
bonds in the protein main chain became stronger (Yamazaki et al., 2006). So the solvent
acidity could change the properties of water, which in turn influence hydrogen bond
formation and indirectly the hydrophobic interactions.

4.5

Metallation State of Encapsulated SOD1
Determining the metallation state of the encapsulated proteins purely based on the

far-UV CD spectra proved to be more challenging than initially thought. This was
primarily due to the fact that the CD region of interest (i.e., below 210 nm) was rather
noisy as shown in this study as well as in a previous work on SOD1 in solution (Fujiwara
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et al., 2005). Despite this, when the encapsulated protein was incubated for longer
periods, certain trends were clear and the CD signal became less noisy over time. The
CD spectra for the encapsulated apo-WT SOD1 and holo-WT SOD1 were in agreement
with the spectra obtained in solution (Arnesano et al., 2004; Potter et al., 2007). The
major difference, however, was that the remetallation of the entrapped apo-WT SOD1 in
sol-gel matrices was not always successful depending on various factors, whereas the
entrapped apo-A4V SOD1 could not be remetallated at all. In the following, the
experiment in which apo-WT SOD1 could not be remetallated is discussed first, followed
by the successful case.
When incubated in EDTA for 54 days, the encapsulated WT SOD1 showed two
conformational changes (Figures 17D-F). In the first seven to nine days, the
conformational changes appeared to be very similar to the solution study (Potter et al.,
2007). However, after a total of 54 days of incubation in EDTA, a new conformational
change was observed that resembled the aforementioned "suspended" partial unfolding
state. After forming this conformation, remetallating the entrapped protein was not
9-1-

possible, even though in solution studies it had been shown that both metals, Zn and
Cu2+, could be added to the apoprotein (DiDonato et al., 2003; Potter et al., 2004). It was
known that, upon metal loss, structural changes took place in the apoprotein; both the
zinc and the electrostatic loops became highly disordered, and the zinc-binding site
94-

became solvent exposed. Yet, in this configuration the Zn

could still be added to the

binding site (Banci et al., 2003). It was suspected, therefore, that the metal binding site
of the entrapped protein was affected by the final conformation. Based on the CD spectra
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shown in Figures 17F-I, the dip in the 225-235 ran region was also indicative of disulfide
bond modification as discussed in the previous section. Thus the long-term incubation in
EDTA (i.e., 54 days) was suspected to induce not only metal loss in the first seven to nine
days (Figure 17E), but also disulfide modification thereafter (Figure 17F). One possible
explanation for this was that after the metal loss, the intra-subunit disulfide bonds were
reduced resulting in two entrapped monomers, which then recombined to form the nonnative intramolecular disulfide bond. Under similar conditions in solution studies (i.e.,
when both metal loss and disulfide reduction occurred), the resulting monomers were
shown to create intermolecular disulfide bonds (Band et al., 2007). However, as
mentioned in the previous section, the entrapped monomers were prevented by the silica
matrix from forming intermolecular disulfide bonds, thus the formation of non-native
intramolecular disulfide bonds was the most probable option. This could be an important
finding for future studies since the remetallation of this species was not possible, and that
could lead to loss of the enzymatic activity (i.e., due to permanent metal loss) as well as
the possibility of an early step in the aggregation pathway.
On the other hand, remetallating encapsulated WT SOD1 was possible under
different incubation conditions. After incubating WT SOD1 in KOAc buffer at pH 5.7
for 54 days, the observed final conformational change was again similar to the apo-WT
protein obtained in solution (Potter et al., 2007), and almost identical to the initial
conformation noticed with EDTA (i.e., 7-9 days) as shown by comparing Figure 1 IF with
Figure 17E. It is important to note that wet sol-gel7 ° was used for both of the samples
used in the previous EDTA experiment and in the one shown in Figure 1 IF. Thus the
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sol-gel pore size or the encapsulation process variation was eliminated as a variable in
this comparison. It was not clear why the protein lost the metal in this case but based on
the CD spectrum, the data certainly implied that possibility. In order to confirm this,
Zn2+ was added to the same sample, and the structural changes observed in Figure 12B
(200-208 nm) were found to be similar to those observed with solution study for holoWT and apo-WT respectively. The conclusion derived from this experiment is that
remetallation of encapsulated apo-WT in sol-gel is possible, and that the failure of
remetallation in the previous test with EDTA is not due to the sol-gel encapsulation but
the structural changes to the protein.

4.6

WT-SOD1: Possible Intermediates or Artifacts
Out of the 660 CD measurements taken in this study, eight measurements showed

abnormal CD spectra that were difficult to reproduce. These measurements were initially
believed to be due to test errors or equipment glitches and thus discarded. However, later
analysis revealed non-random patterns that could be due to a possible intermediate or an
artifact. The observed secondary structure changes in these measurements were all red
shifted with respect to the native fold, and the extent of the red shift seemed to correlate
to the sol-gel process used for encapsulating the proteins as shown in Figures 39 and 40.
With the sol-gel5 7 process, the CD minimum was consistently shifted from 208 to around
215 nm, whereas with the sol-gel

process the minimum was shifted to around 212 nm.

These red shifts were observed only with the entrapped human and bovine WT-SOD1,
but not with the entrapped A4V-SOD1. Considering the number of CD measurements
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taken during this study (i.e., 180 for A4V, 450 for WT, and about 30 for the bovine
SOD1), it was highly unlikely that these measurements represented random artifacts. In
addition, the fact that these anomalous measurements were taken from five different solgel batches and that the extent of the red-shift correlated with sol-gel preparation method
reinforced the possible link to the sol-gel process. However, whether these
measurements represented possible ephemeral intermediates or artifacts related to the solgel process were difficult to determine. To address this, one of the CD measurements
was repeated immediately after noticing the red shift (Figures 40F-F'). In this case the
sample was left in the CD equipment and the measurement was repeated, within five
minutes, without any modifications to the test conditions. As shown in the figure, the
second measurement appeared to be native-like after normalization as compared with the
first. While this strongly suggested the possibility of a sol-gel related artifact, the
possibility of an ephemeral protein intermediate sol-gel related artifact could not be
precluded since these experiments were not repeated due to the limited protein/glass
samples. Glass sample-related artifacts may arise from a rough or inhomogeneous glass
surface facing the light source of the CD spectrometer.
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Figure 39. CD spectra of possible transient intermediates or artifacts with sol-gel5'7. (AB) Same as Figures 11A-B, human WT-SOD1, encapsulated in sol-gel57, batch#l. (CD) Same as Figures 13A-B, sol-gel sample reused. (E-F) Same as Figures 17A-B,
different sample is used from the same batch as above. (G-H) Same as Figures 21G-H,
different sample used from the different batch.
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Figure 40. CD spectra of SOD 1 as possible transient intermediates or artifacts with
different sol-gel methods. (A-B) Same as Figures 31F, F'. (C-D) Same as Figures 311, F.
(E-F) Same as Figures 26D-E'. (G-H) Same as Figures 10A, B. B', D', E', and F' are
normalized spectra of B, D, E, and F, respectively.

4.7

Concluding Remarks
In conclusion, SOD1 entrapment in wet-aged sol-gel is proven to be a viable

approach to obtain unique data that is not possible with solution tests in many cases. It is
hoped that future investigations relating to SOD1 conformational changes will find the
above data useful. The sol-gel encapsulation could be extended to other
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neurodegenerative disorders where aggregation is an issue such as Alzheimer's,
Parkinson's, Huntington's and prion diseases.
Important findings were as follows.
1. Sol-gel encapsulation
• The pH used during the encapsulation process affected the sol-gel pore size,
protein leaching, and protein conformations.
2. Wt protein
• The salt N(CH3)4C1 caused the protein to adopt a stable partially unfolded
secondary structure under near physiological conditions (i.e., pH 7.0 and
crowding). Similar structural changes were also observed under two other
conditions (i.e., pH 4.0 and in TCEP/DTT).
• After 54 days of incubation in KOAc, pH 5.7, loss of Zn

ion occurred in the

absence of a metal chelator.
• The uptake of the Zn 2+ ion by the apo-WT SOD1 was not always possible.
3. A4V protein
• The secondary structure of the encapsulated A4V SOD1 exhibited a common
increase in negative ellipticity in the region between 225 and 240 nm of the CD
spectrum under the following aggregation conditions: KOAc, pH 5.7, EDTA,
and TCEP/DTT.
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Future studies to be considered.
• Testing the encapsulated WT protein using various salts (i.e., other than
N(CH3)4C1) to determine if some of the salts that are abundant in human cells
can cause the aforementioned stable partial unfolding.
• Further analysis of the stable partial unfolding state using a different testing
method than CD such as the fluorescent quenching technique, to study
modifications in protein conformation.

Ill

Appendix A: Protein Charge
Tool used to estimate protein charge at different pH values.
http://www.scripps.edu/cgi-bin/cdputnam/protcalc3;
PDB: 2c9v sequence used for input.

PROTEIN CALCULATOR v3.3
Accepted Sequence
ATKVVCVLKG DGPVQGIINF EQKESNGPVK VWGSIKGLTE GLHGFHVHEF
GDNTAGCTSA 60
GPHFNPLSRK HGGPKDEERH VGDLGNVTAD KDGVADVSIE DSVISLSGDH
CIIGRTLVVH 120
EKADDLGKGG NEESTKTGNA GSRLACGVIG IAQ 153

Estimated charge at pH 7.00 = -4.2
WARNING: pi estimate assumes all residues have pKa values that are equivalent to the
isolated residues. For a folded protein this is not valid. However, this rough value can be
useful for planning protein purifications. pKa values for the individual amino acids from
Stryer Biochemistry, 3rd edition.
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Estimated charge over pH range
PH Charge
4.00 17.1
4.50 11.3
5.00 6.0
5.50 2.8
6.00 0.6
6.50 -1.9

Hi M
7.50 -5.9

SI 91
8.50 -9.0
9.00 -10.9
9.50 -13.3
10.00 -16.4

Both pH 7 and pH 8 are highlighted in green to show the estimated protein net
charge, which is relevant to section 4.1.4.
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